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n	=	 52	 	 159	 	 	
Alter	[Jahre]	 48	±	16	 [10-78]	 70	±	13	 [22-90]	 <	.001	

















































































































































































































































































































































































Population	 Ohne	AKE	 Mit	AKE	 BAV	 TAV	
n	=	 102	 36	 66	 47	 55	
25	mm	 0,27	 0,27	 0,26	 0,28	 0,26	
30	mm	 0,32	 0,33	 0,31	 0,33	 0,31	
35	mm	 0,37	 0,38	 0,35	 0,39	 0,36	
40	mm	 0,43	 0,43	 0,42	 0,44	 0,41	
45	mm	 0,48	 0,49	 0,48	 0,50	 0,47	
50	mm	 0,51	 0,54	 0,53	 0,55	 0,52	















































































































































































































































































































































































































































































































































































































































































































































































































































































































Aortic valve disease with ascending aortic aneurysm: Impact
of concomitant root-sparing (supracoronary) aortic
replacement in nonsyndromic patients
Sven Peterss, MD,a,b Paris Charilaou, MD,a Julia Dumfarth, MD,a Yupeng Li, BS,c Rohan Bhandari, MD,a
Maryann Tranquilli, RN,a John A. Rizzo, PhD,a,c Bulat A. Ziganshin, MD,a,d and John A. Elefteriades, MDa
ABSTRACT
Objective: The purpose of the study was to assess the anticipated incremental risk
of a concomitant aortic resection performed with an aortic valve replacement.
Methods: Patients who underwent aortic valve replacement with root-sparing
ascending replacement were compared with those who underwent isolated aortic
valve replacement using propensity score matching (81 pairs; mean age,
63 ! 11 years [root-sparing ascending replacement] vs 64 ! 14 years). To
evaluate the impact of the technique at distal site, 71 pairs of those undergoing
root-sparing ascending replacement also were matched by propensity score
according to distal anastomosis performed clamped and open under deep
hypothermic circulatory arrest.
Results: Operative mortality was equal between the root-sparing ascending
replacement and isolated aortic valve replacement groups. No significant
difference was found regarding postoperative morbidities, such as bleeding, renal
failure, stroke, and length of stay, except prolonged ventilation was found after
root-sparing procedures (P ¼ .028). Survival estimation showed no difference
between the groups. Comparing the patients undergoing root-sparing ascending
replacement with clamped and opened distal anastomosis revealed a prolonged
ventilation requirement (7% vs 3%; P¼ not significant) in the open group. Oper-
ative mortality was 0% in both groups, and midterm survival was comparable.
Conclusions: The concomitant replacement of the aorta in root-sparing fashion is
associated with an excellent operative outcome and adds no additional risk to
aortic valve replacement in elective and non–high-risk patients. If the distal
anastomosis is performed in an open fashion, while the operative mortality is still
very low, morbidities are slightly higher, but midterm survival remains compara-
ble. (J Thorac Cardiovasc Surg 2016;152:791-8)
AVR with or without ascending aortic resection
showed equal survival.
Central Message
Proximal aortic replacement with the RS tech-
nique is a safe approach and can be performed
with excellent operative results.
Perspective
Resecting the mildly to moderately dilated
aorta at the time of AVR adds no additional
morbidity and mortality risk for patients. These
data are highly relevant to surgical decision
making regarding the management of the aorta
at the time of AVR. These data help to weigh
the operative risk of aortic resection against
the natural risk of aortic dissection and rupture.
See Editorial Commentary page 799.
Weighing the risk of surgical intervention against the
subsequent risks of a disease is essential in recommend-
ing a treatment strategy. In case of co-incidences of aortic
valve disease and proximal thoracic aortic aneurysm, the
assumed additive risk of replacing the aortic vessel
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concomitantly during an aortic valve replacement (AVR)
must be weighed against the potential risk of dissection
and rupture when leaving the aorta alone. But, is there
really a significant surgical risk from incremental aortic
resection? Although a conduit replacement of the valve
and the root, for example, using the Bentall technique,
is known to add technical complexity,1,2 the root-
sparing (RS) approach represents a less difficult
technique, avoiding detachment and reattachment of the
coronary ostia because the proximal anastomosis is
done above the commissures of the native valve.3 Thus,
the operative risk may not be substantial. The essential
requirement for application of the RS technique is a
nondiseased (not significantly dilated) root. In the
1990s, Carrel and coworkers4 reported a mortality of
6.5% with a high incidence of postoperative morbidity
for RS replacement compared with an isolated AVR
(iAVR). However, since then, more complex aortic
procedures have become clinically routine and are
performed with excellent results in experienced centers.5
The aim of this study was to evaluate the modern-day risk
of a concomitant RS supracoronary aortic replacement
compared with the isolated approach of AVR. We also
examined the impact of distal extension of the resection
close or into the aortic arch.
PATIENTS AND METHODS
Study Design
All consecutive patients undergoing AVR and RS (supracoronary)
ascending aortic replacement by a single surgeon between 2004 and 2014
were reviewed for the present study. To compare the specific risk of a
concomitant ascending aortic replacement—controlling for the
general risk of a cardiac surgical procedure and the use of cardiopulmonary
bypass—a contemporaneously operated control group of consecutive iAVRs
was identified. Patients receiving an ascending replacement without an AVR
were excluded from this study. Further exclusion criteria were total aortic
arch replacement, aortic dissection, intramural hematoma, penetrating aortic
ulcer, endocarditis, connective tissue disorder (Marfan, Ehlers–Danlos,
Loeys–Dietz), transcatheter approaches, root replacement (Bentall, Cabrol,
David, or Yacoub procedure), root remodeling, and concomitant coronary
artery bypass grafting procedure.
Group propensities were adjusted by propensity score matching (details
noted in ‘‘Statistical Analysis’’ section), and demographic characteristics,
comorbidities, operative data, postoperative morbidity, and early outcome
were analyzed by comparing the study group with the control group. Late
complications were analyzed according to Akins and colleagues.6 In a
second step, the population receiving RS procedures was divided into 2
subgroups according to distal extension into the arch (clamped vs open
distal anastomosis) requiring the use of deep hypothermic circulatory arrest
(DHCA), and a comparison was performed after propensity score
matching. Survival after discharge was determined from the Social
Security Death Index and chart review, and the date of proven last
clinical contact was used for the status ‘‘alive.’’ The Human Investigation
Committee of Yale University approved this retrospective study, and all
patients signed informed consent.
Patient Population
Between 2004 and 2014, 182 consecutive patients with concomitant
aortic valve and ascending aortic aneurysm disease (RS) (mean age,
61! 13 years; 60% were male) and 159 patients with isolated aortic valve
disease (iAVR) (mean age, 70 ! 13 years; 59% were male) underwent
operation at Yale-New Haven Hospital by 1 surgeon (JAE) and met the
criteria of the present study. Among those, 81 pairs were matched for
comparison using the propensity score model. The demographic and
medical characteristics are presented in Table 1.
Subgroup Population
Among the 182 patients undergoing the concomitant AVR and RS
procedure, 96 underwent an open distal anastomosis using DHCA and 86
received an approach limited to the ascending aorta without the need for
DHCA. To compare outcomes for these 2 subgroups, we used matching
techniques on them. Among those groups, 71 patients each matched for
comparison using the propensity score model were included in the analysis.
Demographics and characteristics are shown in Table 1.
Surgical Indication and Procedure
According to guidelines, a diameter of 45 mm represents the indica-
tion to concomitantly replace the aorta in case of an indicated cardiac
procedure at the Aortic Institute.7 None of the patients in the iAVR group
met this criterion. In the RS group, the aorta was replaced at a diameter of
45 mm or greater in 111 patients, 40 to 44 mm in 19 patients, and less
than 40 mm in 6 patients, according to our institutional policy regarding
co-incidental diseases and biometrical adjustment.8,9
All procedures were performed using a total median sternotomy. The
aortic valve was implanted by an intra-annular technique, and the ascending
aorta, if applicable, was resected above the aortic valve commissures. An
open distal anastomosis was distinguished by the lack of supra-aortic branch
disconnection and reimplantation. If circulatory arrest was applicable, deep
core temperatures approaching 18"C to 19"C were used, followed by an
extendedwarming.No adjunct selective organ perfusion techniquewas used.
Statistical Analysis
The matching between the respective groups was done by using a
propensity score model including the following variables: age, gender,
aortic valve stenosis, bicuspid valve morphology, symptomatic
disease, arterial hypertension, pulmonary hypertension, left ventricular
ejection fraction 35% or less, coronary artery disease, atrial fibrillation,
history of smoking, chronic obstructive pulmonary disease, diabetes,
chronic renal failure, hemodialysis, and history of stroke. The
propensity score model was matched using nearest neighbor matching
with a caliper of 0.25. Matching covariates and standardized difference
of the mean are shown in Figure 1 and Table E1.
Data are presented as frequency distributions and percentages for
categoric variables or as mean ! standard deviation for continuous
variables. The Pearson chi-square test or Fisher exact test was used when
analyzing categoric variables, the Student t test or Mann–Whitney U test
was used for continuous variables, and the Kaplan–Meier survival
estimate was used for survival analysis. The Gehan–Breslow–Wilcoxon
test (for detecting significance mostly in the earlier time period) was
used to compare the estimated survival of different populations.
Statistical analysis and matching were performed using SPSS version
Abbreviations and Acronyms
AVR ¼ aortic valve replacement
DHCA ¼ deep hypothermic circulatory arrest
iAVR ¼ isolated aortic valve replacement
RS ¼ root sparing
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In the propensity score–corrected population, cardiopul-
monary bypass times were 91.1! 14.4 minutes (iAVR) and
144.1! 25.7 minutes (RS) (P<.001), and crossclamp times
were 68.0 ! 11.7 minutes (iAVR) and 99.8 ! 13.9 minutes
(RS) (P<.001), and thus differ by 53 and 32 minutes. Distal
anastomosis was performed open in 53% of the patients,
requiring 25.9 ! 3.7 minutes of circulatory arrest at
19.1"C ! 0.8"C on average. No additional selective
cerebral perfusion strategy was used according to our
institutional protocol.10 Technical complications were
noted in 3% of patients (RS) and 1% of patients (iAVR),
in the majority of the cases represented by a secondary
change of the valve prosthesis to a smaller size or
reconstruction of the femoral artery due to arterial
cannulation. Further operative details are noted in the
Appendix (Table 2).
Postoperative Outcome
Among the propensity score–corrected comparison,
patients undergoing concomitant aortic surgery experi-
enced a higher incidence of prolonged ventilation (7% vs
0%, P ¼ .028) and longer stay in the intensive care unit
(3.7 ! 3.5 days vs 2.8 ! 1.5 days, P ¼ .025). In-hospital
TABLE 1. Demographics and characteristics
n ¼
Propensity score–matched cohort
iAVR AVR þ RS
P value
Clamped anastomosis Open distal anastomosis
P value81 81 71 71
Age, y 63.5 ! 13.6 63.1 ! 11.2 .821 60.4 ! 11.6 60.0 ! 13.3 .861
Male gender 55 (68%) 56 (69%) 1.000 48 (68%) 46 (65%) .859
BMI 28.1 ! 5.2 28.2 ! 5.9 .848 29.5 ! 6.4 28.3 ! 5.9 .291
STS risk score
Operative mortality,% 1.15 ! 0.88 1.07 ! 0.66 .515 0.92 ! 0.55 0.99 ! 0.62 .458
Major morbidity or operative
mortality,%
10.15 ! 3.43 10.17 ! 3.3 .972 9.38 ! 2.94 9.73 ! 2.88 .472
Aortic valve disease
Stenosis 63 (78%) 53 (65%) .116 44 (62%) 39 (55%) .496
Mean pressure gradient, mm Hg 48.7 ! 13.7 41.1 ! 15.6 .014 44.5 ! 17.2 38.9 ! 17.0 .188
Valve area, cm2 0.72 ! 0.16 0.90 ! 0.34 .002 0.85 ! 0.25 0.97 ! 0.39 .140
Insufficiency 18 (22%) 28 (35%) .116 27 (38%) 32 (45%) .496
Valve morphology
Bicuspid 56 (69%) 56 (69%) 1.000 58 (82%) 52 (73%) .315
Aortic diameter
Root 33.8 ! 5.3 35.9 ! 6.2 .112 37.4 ! 6.7 36.9 ! 5.9 .729
Ascending 34.8 ! 4.4 48.5 ! 7.6 <.001 46.4 ! 5.8 50.6 ! 7.6 <.001
Arch 27.9 ! 3.7 28.9 ! 5.0 .409 28.9 ! 5.1 30.6 ! 5.5 .237
Bovine arch 0 (-) 4 (5%) .120 1 (1%) 6 (9%) .116
Comorbidities
Symptomatic 70 (86%) 63 (78%) .218 44 (62%) 43 (61%) 1.000
Arterial HT 59 (73%) 66 (82%) .261 56 (79%) 55 (78%) 1.000
Pulmonary HT 5 (6%) 5 (6%) 1.000 0 (-) 0 (-) -
LVEF 56.8 ! 12.1 56.8 ! 10.4 .977 58.1 ! 9.6 57.8 ! 8.6 .833
Coronary artery disease 10 (12%) 10 (12%) 1.000 6 (9%) 8 (11%) .779
Atrial fibrillation 7 (9%) 7 (9%) 1.000 5 (7%) 6 (9%) 1.000
History of smoking 32 (40%) 26 (32%) .413 20 (28%) 23 (32%) .715
COPD 11 (14%) 6 (7%) .305 5 (7%) 4 (6%) 1.000
Dyslipidemia 46 (57%) 43 (53%) .752 40 (56%) 39 (55%) 1.000
Diabetes 13 (16%) 14 (17%) 1.000 10 (14%) 12 (17%) .817
Chronic renal failure 5 (6%) 4 (5%) 1.000 1 (1%) 2 (3%) 1.000
Creatinine 0.91 ! 0.28 0.89 ! 0.23 .373 0.86 ! 0.21 0.91 ! 0.23 .156
History of stroke 4 (5%) 4 (5%) 1.000 2 (3%) 3 (4%) 1.000
Data are shown as mean ! standard deviation, number (percentage) or as [reported]. Bold values are statistically significant (P<.05). iAVR, Isolated aortic valve replacement;
AVR, aortic valve replacement; RS, root-sparing; BMI, body mass index; STS, Society of Thoracic Surgeons; HT, hypertension; LVEF, left ventricular ejection fraction;
COPD, chronic obstructive pulmonary disease.
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stay and other comorbidities, such as bleeding, renal failure,
and stroke, showed no difference between the groups.
Operative mortality was 0% in both groups. Details are
shown in Table 3.
Follow-up and Survival
Survival expressed by the Kaplan–Meier survival
estimation in Figure 2 showed no significant difference
between the groups (P ¼ .7237).
During follow-up, no patient in the RS group required a
secondary root replacement due to progressive root dilation;
only 1 patient had a pseudoaneurysm of the suture line
(infection) and underwent redo ascending replacement
4 months after prior surgery.
Mean follow-up time was 4.7 " 3.4 years (RS) and
4.9 " 3.4 years (iAVR). No significant differences were
found in late complications regarding secondary aortic
valve replacement, complete heart block, pericardial
and pleural effusion, left ventricular ejection fraction
decline, need for automated implantable cardioverter-
defibrillator, transitory ischemic attack, stroke, endocar-
ditis, renal failure, patient–prosthesis mismatch, or struc-
tural and nonstructural prosthesis deterioration after
discharge.
Distal Anastomosis Technique (Subgroup Analysis)
The subgroup analysis of the concomitant RS ascending
replacement cases, divided according to the type of distal
TABLE 2. Operative data
Propensity score–matched cohort
iAVR AVR þ RS P value Clamped anastomosis Open distal anastomosis P value
CPB time, min 91.1 " 14.4 144.1 " 25.7 <.001 127.3 " 16.3 159.9 " 18.8 <.001
Crossclamp time, min 68.0 " 11.7 99.8 " 13.9 <.001 103.3 " 14.2 98.6 " 15.4 .066
DHCA 0 (-) 43 (53%) <.001 0 (-) 71 (100%) <.001
DHCA time, min - 25.9 " 3.7 - - 25.6 " 4.9 -
Lowest core temperature, $C - 19.1 " 0.8 - - 18.9 " 0.6 -
Arterial cannulation
Ascending aorta/arch 81 (100%) 10 (12%) <.001 9 (13%) 3 (4%) .129
Femoral artery 0 (-) 67 (83%) <.001 61 (86%) 66 (93%) .275
Axillary artery 0 (-) 4 (5%) .120 1 (1%) 2 (3%) 1.000
Prosthesis
Mechanical 39 (48%) 34 (42%) .528 35 (49%) 35 (49%) 1.000
Biological 42 (52%) 47 (58%) 36 (51%) 36 (51%)
Size, mm 21.6 " 2.2 22.3 " 2.0 .049 22.5 " 2.0 22.5 " 2.2 .967
Primary procedure
RS technique - 81 (100%) - 71 (100%) 71 (100%) -
Open distal anastomosis - 43 (53%) - 0 (-) 71 (100%) -
Concomitant procedure 9 (11%) 15 (19%) .269 12 (17%) 11 (16%) 1.000
Annuloplasty 1 (1%) 0 (-) 1.000 0 (-) 0 (-) -
Technical complication 1 (1%) 2 (3%) 1.000 3 (4%) 4 (6%) 1.000
Data are shown as mean " standard deviation, number (percentage) or as [reported]. Bold values are statistically significant (P<.05). iAVR, Isolated aortic valve replacement;
AVR, aortic valve replacement; RS, root-sparing; CPB, cardiopulmonary bypass; DHCA, deep hypothermic circulatory arrest.
FIGURE 1. Covariate balance for (A) study analysis and (B) subgroup analysis before and after propensity score matching. pulm, Pulmonary; LVEF, left
ventricular ejection fraction; hx, history; Art, arterial; COPD, chronic obstructive pulmonary disease.
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anastomosis (open and with DHCA or clamped and without
DHCA), showed no significant differences in the postoper-
ative morbidity, mortality, and length of stay. The stroke
rate was low in both subgroups, with 0% (an approach
limited to the ascending aorta without the need for
DHCA) and 1% (open distal anastomosis using DHCA).
Midterm analysis showed comparable survival in patients
who underwent open extension with DHCA compared
with those with a clamped distal anastomosis in midterm
view (P ¼ .0533). However, long-term survival differed
significantly between the distal anastomosis type groups,
from year 5 onward (log rank [Mantel–Cox] test:
P ¼ .0213). Survival is shown in Figure 3, and further
details are outlined in Tables 2 and 3.
DISCUSSION
Aortic valve disease and ascending aortic aneurysm are
often associated with various causes. In addition to hemo-
dynamic flow patterns with aberrant mechanical forces
causing a poststenotic aortic dilation, intrinsic genetic
and physiologic abnormalities of the aortic wall are known
to be at play (eg, Marfan disease, bicuspid aortic valves).9
Moreover, an aneurysm of the aorta itself can cause aortic
valve insufficiency by dilating the valve scaffold and
reducing the coaptation area of the cusps. In case of the
co-incidence of both diseases (diseased aortic valve and
aorta), it still remains controversial whether a more pre-
ventive approach or a more restrained posture regarding
the aorta is indicated.11 Opponents of an aggressive
TABLE 3. Early postoperative outcome
Propensity score–matched cohort
iAVR AVR þ RS P value Clamped anastomosis Open distal anastomosis P value
Reexploration due to bleeding 5 (6%) 4 (5%) 1.000 4 (6%) 3 (4%) 1.000
Morbidity
Ventilation>48 h 0 (-) 6 (7%) .028 2 (3%) 5 (7%) .441
LCOS 0 (-) 1 (1%) 1.000 1 (1%) 1 (1%) 1.000
With IABP 3 (4%) 3 (4%) 1.000 1 (1%) 1 (1%) 1.000
With ECLS/ECMO 0 (-) 1 (1%) 1.000 0 (-) 1 (1%) 1.000
Myocardial infarction 0 (-) 1 (1%) 1.000 0 (-) 1 (1%) 1.000
Atrial fibrillation* 9 (11%) 7 (9%) .793 6 (9%) 5 (7%) 1.000
AV block III* 7 (9%) 4 (5%) .534 4 (6%) 6 (9%) .745
Pacemaker 10 (12%) 4 (5%) .160 4 (6%) 6 (9%) .745
Renal failure* 4 (5%) 4 (5%) 1.000 2 (3%) 3 (4%) 1.000
Stroke 1 (1%) 1 (1%) 1.000 0 (-) 1 (1%) 1.000
Infection 6 (7%) 5 (6%) 1.000 2 (3%) 2 (3%) 1.000
Sepsis 0 (-) 0 (-) - 0 (-) 0 (-) -
Composite morbidityy 10 (12%) 11 (14%) 1.000 8 (11%) 10 (14%) .802
Length of stay
ICU, d 2.8 # 1.5 3.7 # 3.5 .025 2.9 # 1.4 3.5 # 3.0 .143
Median (25-75 percentile) 3.0 (2.0-3.0) 3.0 (2.0-4.0) .029 2.0 (2.0-3.0) 3.0 (2.0-4.0) .323
In-hospital, d 5.9 # 1.9 6.4 # 4.0 .321 5.6 # 1.3 6.1 # 3.6 .231
Median (25-75 percentile) 5.0 (5.0-6.0) 5.0 (5.0-6.0) .520 5.0 (5.0-6.0) 5.0 (5.0-6.0) .596
Operative mortalityz 0 (-) 0 (-) - 0 (-) 0 (-) -
1-y survival,% 97.3 # 1.9 98.8 # 1.2 100 # 0 98.6 # 1.4
5-y survival,% 88.3 # 4.3 92.8 # 3.1 98.4 # 1.6 95.6 # 2.5
Data are shown as mean # standard deviation, number (percentage) or as [reported]. Bold values are statistically significant (P<.05). iAVR, Isolated aortic valve replacement;
AVR, aortic valve replacement; RS, root-sparing; LCOS, low cardiac output syndrome; IABP, intra-aortic balloon pump; ECLS, extracorporeal life support; ECMO, extracorporeal
membrane oxygenation; AV, aortic valve; ICU, intensive care unit. *Postoperative new-onset. yIncluding reexploration, prolonged ventilation, stroke, renal failure, low cardiac
output syndrome, and sepsis. zClassified as in-hospital mortality plus 30-day mortality of discharged patients; length of stay refers to the postoperative period.
FIGURE 2. Kaplan–Meier survival estimation after propensity score
matching of the concomitant RS aortic replacement group compared
with the control group undergoing an iAVR approach. AVR, Aortic valve
replacement; iAVR, isolated aortic valve replacement; RS, root sparing.
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approach argue that a concomitant aortic replacement in-
creases the operative risk compared with an isolated valve
replacement.
This study shows that adding an RS ascending
aortic replacement—representing the surgically simplest
approach regarding the proximal anastomosis of the
diseased aorta—is associated with no higher operative
risk than an iAVR. In fact, this risk was 0%. The overall
incidence of postoperative morbidity also was low,
especially regarding the reexploration rate (4%) and
postoperative strokes (1%). Only a higher incidence of
prolonged ventilation (7% vs 0%) was found. Intensive
care unit and in-hospital stays were brief (2-4 and 5-
6 days, respectively). None of the patients with concomitant
aortic surgery died within 30 days.
Studies from the University of Virginia, University of
Toronto, Northwestern University, and, most recently,
University of Udine, focusing on bicuspid valves, presented
similarly favorable results and confirm the safety of the RS
approach found in the present study.12-15
Even by extending the surgical approach close to or
into the arch portion (with an open distal anastomosis
and the need for DHCA), the postoperative outcomes re-
mained favorable, with a mortality of 0%. Because of the
more complex operative approach, a slightly higher inci-
dence of prolonged ventilation (5%-7% vs 3%-4%),
renal failure (4% vs 2%-3%), and postoperative need
for antibiotic treatment (infection 3%-5% vs 2%-3%)
were found. An open distal anastomosis represents an
entirely resected ascending portion without remaining re-
sidual. We think the open distal anastomosis is a techni-
cally easier approach, reflected by a decreased
crossclamp time of 4 to 5 minutes (Table 2). However,
this technique also requires hypothermic circulatory
arrest with a consequently prolonged time on cardiopul-
monary bypass due to cooling and rewarming (32-33 mi-
nutes in the present study) and the necessity of a cerebral
protection strategy.
At our institution, straight deep hypothermic arrest
(targeting 18!C-19!C) represents the established routine
of brain and organ protection. In a former study by our
group, Gega and colleagues16 found a stroke rate of
2.3% and mortality of 2.0% in elective cases using this
technique. Later, Ziganshin and colleagues10 confirmed
these good results, analyzing arch replacements and re-
porting strokes in 1.2% and early mortality in 1.4% of
the cases, one third due to cerebral-associated causes.
The safe duration of DHCA was evaluated as within 40
and 50 minutes in these studies. In comparison with
adjunct brain protection techniques, straight DHCA was
found as effective as more complex perfusion approaches
and furthermore provides an unimpaired surgical view by
the lack of additional perfusion catheters in or cannulas
close by the operative field.17,18 In the present study, the
mean time of DHCA was completely within the safe
period, lasting 25 to 26 minutes on average, with a
range from 11 to 46 minutes. Femoral cannulation
represents our standard technique and provides
simplicity and effectiveness.19,20 We reserve an axillary
approach for cases with a ‘‘dirty’’ aorta on preoperative
computed tomography or intraoperative transesophageal
echocardiography.
Is sparing the root and leaving a portion of the very
proximal native aortic tissue a sufficient approach or do
we risk the manifestation of root aneurysms later?
Replacing the root as a redo procedure certainly is
associated with an appreciable operative risk and mortality.
By analyzing the biomechanical parameters of a spared
root, Simon-Kupilik and coworkers21 found a significant
increase of hemodynamic burden after ascending graft
replacement. They reported an increase in the wall stress
index in the native root of 22% (in vitro) and 16%
(in vivo). Rinewalt and colleagues12 advocated a more
aggressive intervention, recommending Bentall procedures
to avoid reoperations. However, in our opinion, sparing the
root is a legitimate technique for 2 reasons: First, a
replacement of the root requiring reimplantation of the
coronary arteries is associated with a slightly higher
operative risk.2 In a large meta-analysis, Castrovinci and
colleagues22 found a stroke rate of 3.7% (range,
0%-29%), myocardial infarction rate of 2.9% (range,
0%-13%), and bleeding complications requiring operative
reexploration rate of 7.6% (range, 0%-27%). In-hospital
mortality was 6.4% (range, 0%-25%). Second, the aortic
root grows slowly, slower than the other portions of the
aorta. In a recent analysis from our institution, the
growth rate was found at 0.41 mm per year (range,
0.27-0.51 mm/year according to the initial diameter
FIGURE 3. Kaplan–Meier survival estimation after propensity score
matching comparing clamped technique for distal site and open distal
anastomosis (with DHCA). RS, Root-sparing; DHCA, deep hypothermic
circulatory arrest; RSXc, approach limited to the ascending aorta without
the need for DHCA; RSopen, open distal anastomosis using DHCA.
Acquired: Aortic Root Peterss et al







[25-50 mm]), regardless of valve morphology or
concomitant valve replacement. We calculated (on the basis
of a comparable mean root diameter as in the present study)
and according to our institutional criteria (root replacement
at 50 mm) that subsequent aortic root replacement would
not be required for 29 years or more.23 The most recent
findings of Vendramin and coworkers15 clinically support
these data.
As mentioned in the beginning of this article, the
separation of benefit from harm is essential but difficult. It
still remains controversial in the literature which aortic
diameter triggers the surgical decision for aortic
intervention in cases of primary aortic valve disease. Also
controversial is whether bicuspid valve morphology indi-
cates a resection at earlier stages.11,24-28 Verma and
colleagues11 analyzed (using a survey) the variety of aortic
treatments in the presence of bicuspid valve morphology
among Canada’s adult cardiac surgeons. They found that
the threshold for resection the aorta in case of a nondiseased
bicuspid valve was 55% at 50 mm and 23% at 45 mm,
whereas a diseased valve lowers the threshold to 45 mm
in 61% and to 40 mm in 29% of the surgeons’ decisions.
However, the good results reported in the current article
and others12-15 for the RS approach advocate for a more
liberal treatment in elective patients.
Despite our institutional policy and the guidelines recom-
mending concomitant aortic replacement at a diameter of
45 mm (Class I, evidence level B),29 it must be recognized
that the risk of subsequent aortic events after iAVR consis-
tently has been low. In patients presenting with a diameter
larger than 40 mm during initial iAVR, McKellar and
colleagues30 from the Mayo Clinic found (analyzing
exclusively bicuspid morphologies) only slightly less
freedom from aortic events (aortic dissection, surgery, and
enlargement) of 75% to 85% within 15 years, compared
with those with smaller diameter (88%-93% freedom). In
a recent study neglecting initial diameter, Itagaki and
colleagues31 from the Mount Sinai group reported a
generally low incidence of aortic-related diseases after
iAVR. The 15-year cumulative incidence of aortic
dissection, aortic aneurysm, and the need for thoracic aortic
surgery was 0.6%, 4.8%, and 2.5%, respectively, for
patients with bicuspid valve morphology and 0.4%,
1.4%, and 0.5%, respectively, for nonbicuspid and
non-Marfan cases. Following the current guidelines, no
aortic event (aortic dissection or need for thoracic aortic
surgery) occurred in our patients undergoing iAVR during
follow-up in the present study.We have shown that concom-
itant aortic surgery can be performed safely, but we have not
proven that this was necessary.
Study Limitations
This is a retrospective study with the inherent limitations
for such an analysis. We caution regarding the extrapolation
of our results to higher-risk older patients. Also, we used a
single cutoff value (45 mm ascending diameter) for the
decision to resect the ascending aorta. Although this cutoff,
representing our institutional policy, is consistent with
guidelines,29 our study cannot determine the appropriate
criterion (eg, in the range of 40-50 mm) for concomitant
aortic resection at the time of AVR. A randomized study
would be necessary to focus on diameters between 40 and
50 mm, including cofactors such as height, family history
of dissection/rupture, connective tissue disorders, valve
morphology, and other ‘‘associations.’’9 This study
represents a single-surgeon observation. Although such
types of patient cohorts are limited in number and thus
the potential number after matching is limited, it also pro-
vides uniformity in decision making, treatment, surgical
quality, and clinical experience, which may counterbalance
the detriments. Despite these limitations in statistical
criteria and variables, we should not lose track of the
main findings of this study: The technical performance of
incremental concomitant supracoronary aortic replacement
can be accomplished at a low surgical risk (0% in this
study).
CONCLUSIONS
Concomitant aortic valve and RS aortic replacement can
be performed as safely as an iAVR in elective patients. If an
extension close to or into the arch portion is advised, the
operative mortality is still low and morbidity is slightly
higher, but survival remains comparable. Thus, in experi-
enced centers, an RS ascending replacement in aneurysmal
patients, without a dilated aortic root and without
syndromic connective tissue disorder, can be performed in
addition to AVR without hesitation; furthermore, an open
distal anastomosis, if necessary, should not be ruled out.
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TABLE E1. Matching model results
n per group ¼
Propensity score–matched cohort
Study analysis Subgroup analysis
81 71
Age 0.030 0.031







Arterial HT 0.166 0.034
Pulmonary HT 0.051 NA
LVEF "35% 0.047 0
Coronary artery disease 0.037 0.101
Atrial fibrillation 0 0.055
History of smoking 0.151 0.093
COPD 0.179 0.055
Diabetes 0.033 0.080
Chronic renal failure 0.051 0.119
Hemodialysis NA NA
History of stroke 0 0.085
Data are shown as standardized difference of the mean. HT, Hypertension; LVEF, left
ventricular ejection fraction; COPD, chronic obstructive pulmonary disease; NA, not
applicable.
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The Aortic Root: Natural History After
Root-Sparing Ascending Replacement in
Nonsyndromic Aneurysmal Patients
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Gregory A. Kuzmik, MD, Bulat A. Ziganshin, MD, and John A. Elefteriades, MD
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Surgery, University Hospital Munich, Ludwig Maximilian University, Munich, Germany; Departments of Economics and Preventive
Medicine, Stony Brook University, Stony Brook, New York; China Center for Health Development Studies, Peking University, Beijing,
China; and Department of Surgical Diseases 2, Kazan State Medical University, Kazan, Russia
Background. Leaving native aortic tissue in situ in root-
sparing ascending aortic replacement raises concern
regarding potential later need for root reoperation or for
the potential occurrence of localized dissections or
rupture in the residual root. The purpose of this study
was to evaluate the natural growth of the aortic root after
root-sparing aortic replacement.
Methods. In all, 102 consecutive patients (mean age
61.8 ± 12.5 years; 60% male) who had undergone root-
sparing aortic replacement had sufﬁcient retrievable
information regarding their aortic root diameter at
postoperative baseline and follow-up imaging by
computed tomography or echocardiography. The annual
growth rate was evaluated and also compared according
to the inﬂuence of valve morphology and concomitant
aortic valve replacement. Furthermore, the years of
natural history that would require for root enlargement
to meet a 50 mm threshold of the root diameter were
calculated.
Results. The estimated growth rate of the aortic root
after root-sparing aortic replacement is between 0.27 and
0.51 mm per year (mean 0.41 mm, varying according to the
underlying diameter) and therefore ﬁvefold less than
other aortic regions. Accordingly, a root aneurysm indi-
cating reoperation would not be expected for 29.1 years
on average. Only patients with a diameter of 45 mm or
more are at risk for reoperation, and not until at least after
10.4 years have passed. Neither the valve morphology
(p [ 0.62) nor concomitant aortic valve replacement
(p [ 0.86) inﬂuenced rate of root dilation.
Conclusions. Innonsyndromicpatients, the aortic root is
the slowest growing portion of the thoracic aorta. Leaving
the native root, as in root-sparing ascending aortic
replacement, is a safe approach regarding secondary root
intervention for aortic root diameters of 45 mm or less.
(Ann Thorac Surg 2017;103:828–33)
! 2017 by The Society of Thoracic Surgeons
The incidence of thoracic aortic aneurysms has beendetermined to be approximately 6 to 15 cases per
100,000 patient-years [1–3]. Approximately 60% of the
aneurysms involve proximally the aortic root or
ascending portion, 10% the aortic arch, 40% the
descending, and 10% the thoracoabdominal region (some
patients have dilations at more than one level) [4]. Aortic
dissection and rupture are the most devastating natural
complications of aortic aneurysm, and data from our
group revealed aneurysm size to be an important pre-
dictor in the course of these events [5]. Whereas the in-
ternational guidelines follow a more conservative
approach (recommending replacement at 55 mm in case
of the proximal aortic regions [6–8]), most specialized
centers tend to intervene on the proximal aorta at
somewhat smaller sizes.
It still remains controversial at which size a proactive
replacement of a speciﬁc portion of the aorta is indicated
and how extensive the resection should be, especially in
case of the aortic root [9]. Sparing a nondilated or slightly
dilated root during an ascending replacement simpliﬁes
the surgical technique, but concern exists when leaving
the native root in situ with regard to further, future
dilation. The concerns surround possible dissection and
rupture in the residual root segment or potential need for
reoperation for progressive dilation.
Despite these concerns, the speciﬁc growth dynamic of
the root is not well reported for nonsyndromic (for
example, non–Marfan syndrome) patients in the litera-
ture. The aim of this study was to quantify the natural
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growth of the residual nonaneurysmal aortic root portion
after root-sparing ascending aortic replacement. We also
aimed to estimate the interval until a reoperation after a
root-sparing approach might be necessary. Furthermore,
we tried to determine the inﬂuence of concomitant aortic
valve replacement (AVR) and of different valve mor-
phologies on the dilation progress.
Patients and Methods
Study Design
To determine the natural growth rate of the aortic root,
we analyzed postoperative inner root diameters in
patients who received root-sparing/supracoronary
ascending replacements, and determined rates accord-
ing to initial root size. Further subanalyses were per-
formed to evaluate a possible stabilizing effect of a
concomitant AVR on the growth rate of the root and any
potential impact of the natural aortic valve morphology.
The study was approved by the Human Investigation
Committee of the Yale University School of Medicine. All
patients gave written informed consent for participation
in the study.
Inclusion Criteria
All consecutive patients undergoing a root-sparing/
supracoronary ascending aortic replacement at the Yale
Aortic Institute between 2004 and 2011 were retrospec-
tively reviewed in this study. Patients with two or more
retrievable images or evaluable transparent measure-
ments were included. Postoperative imaging assessments
were done according to Institute policy regarding follow-
up consultations and images. Patients after 2011 were
excluded both to prevent measurement errors from short
follow-up (due to an expected slow growth rate) and to
ensure identifying secondary aortic root dilation. Within
this time frame, a total of 366 aneurysm patients under-
went elective ascending aortic replacement by a root-
sparing technique and were reviewed according to the
inclusion criteria. Contemporaneously, a root replace-
ment was performed in 239 aneurysm patients [10].
Exclusion Criteria
According to the aim of the study, the following exclusion
criteria were deﬁned: root remodeling/replacement
operation (any type), syndromic genetic disorders
(Marfan syndrome, Ehlers-Danlos, and others), aortic
dissections, intramural hematomas, and redo cardiac
operations.
Data Collection and Analysis
This study was performed retrospectively. To determine
growth rates, baseline computed tomography (CT) or
echocardiography imaging was reviewed for all patients
after surgery and compared with subsequent available
imaging studies. Aortic root variables were measured by
two cardiac surgeons independently (J.A.E. and S.P.) and
evaluated from imaging reports (if those reported sepa-
rately sizes for the annulus, sinus of Valsalva, sinotubular
junction, and ascending aorta) from Department of
Radiology or Department of Cardiology at Yale–New
Haven Hospital. For quality control, repetitive blinded
and randomly assigned reviews were performed in 100
imaging studies (31.8%). If an interobserver discrepancy
greater than 5% was detected (between measurements of
the two surgeons, or between the surgeons’ measure-
ments and the radiology reports), for each such patient a
collaborative decision was reached between the surgeons
and the radiologists regarding the size of the aorta to
include in the study (12.4%; 14 of 113 identiﬁed patients)
[11]. Owing to the known and identiﬁed interobserver
differences in evaluating the aortic root sizes by either of
theses modalities and to enhance transparency of the
taken measures, reports from outside institutions were
excluded. The impact of imaging modality—echocardi-
ography (12.4%; 14 of 113) or CT (87.6%; 99 of 113)—was
tested and was highly insigniﬁcant (p ¼ 0.54). Therefore,
the modality had virtually no effect on the other esti-
mated coefﬁcients of the growth model in the present
study.
The measurements were taken at the maximum inner
diameter of the sinus of Valsalva and compared with later
measurements by the same modality in the same planes
(because of the known differences between ultrasono-
graphic and radiographic evaluation) [12]. With regard to
the surgical procedure—ascending aortic replacement
with or without AVR—measurements at the annulus and
sinotubular junction were renounced owing to proximity
of the anastomosis site.
We also calculated the number of years needed to reach
50 mm and 55 mm intervention thresholds. However,
according to our institutional policy, indication for oper-
ative repair of aortic root aneurysm (in an asymptomatic
patient) is a diameter greater than 45 mm, or an annual
dilation of 5 mm or more (very rare), except in higher risk
patients or if contraindications exist.
Statistical Analyses
As described previously by our group, we analyzed the
growth rate of the aortic root by performing a multivar-
iate regression analysis to estimate the growth pattern
[13, 14]. Further details are reported in the Appendix.
Results
Patient Population and Follow-Up
Between 2004 and 2011, 113 patients underwent elective
ascending aortic replacement by a root-sparing technique
and fulﬁlled the inclusion and exclusion criteria. Among
these, 9 patients were excluded owing to incomplete
follow-up data by collaborative decision round and
another 2 patients were determined to be outliers with
observed aortic measurements greater than two standard
deviations from the mean by our statistical experts.
Therefore, the ﬁnal cohort in this study consisted of 102
patients. However, as a number of patients had more than
one imaging studies, 199 observations (change in aortic
size between two images) were available for statistical
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analysis. Mean time between ImageT-1 and ImageT was
19.55 ! 16.52 months (range, 0 months to 8.75 years), and
between ﬁrst postoperative and most recent image,
41.62 ! 26.08 months (range, 2 months to 9.17 years).
Patient demographics, characteristics, and comorbidities
are depicted in Table 1.
Surgical Data
The proximal ascending aorta was replaced in all patients
by a root-sparing technique; 66 of those (63.7%) received a
concomitant AVR. In the distal ascending portion, 74
patients (72.5%) underwent extension into the arch under
deep hypothermic circulatory arrest. Among those, the
hemiarch was replaced in 60 (58.8% of all patients) and
the total arch in 14 (13.7% of all patents). An elephant
trunk stage-1 procedure was performed in 11 patients
(10.8% of all patients). Sixteen patients (16%) underwent
concomitant coronary artery bypass graft surgery.
Aortic Root Diameter and Growth Rate
The mean postoperative baseline diameter was 37.4 !
3.76 mm (range, 27 to 48 mm), evaluated 5.63 ! 1.29
months postoperatively on average. Owing to inclusion of
longitudinal observations, mean sizes at ImageT and
ImageT-1 were 38.79 ! 3.55 mm (range, 28 to 48 mm) and
38.20 ! 3.51 mm (range, 27 to 47 mm), respectively. In
multivariate regression analysis, the coefﬁcient on TIME
was positive (0.000652) and highly signiﬁcant (p < 0.0001).
That indicates that the aortic root does grow over time.
Mean growth rate is estimated at 0.41 mm per year (95%
conﬁdence interval: 0.35 to 0.46 mm per year). According
to initial root size, the growth rate increases with larger
diameter (Table 2, Fig 1). The time interval until 50 mm
would be reached would be 29.1 years on average (Fig 2).
Effect of Contemporaneous AVR and Valve Morphology
on Root
The dilation of the root is estimated respectively at 0.40
mm per year on average with concomitant AVR and at
0.42 mm per year on average without AVR. The coefﬁ-
cient on the interaction term AVR*TIME in multivariate
regression analysis is small ("0.0000230) and insigniﬁcant
(p ¼ 0.86). These ﬁndings indicate that growth in the
aortic root is unaffected by concomitant AVR after the
root-sparing operation.
The distribution by native aortic valve morphology
showed dilation of 0.42 mm per year for bicuspid valves
and of 0.40 mm per year for tricuspid valves on average.
The coefﬁcient on the interaction term BAV*TIME is also
small (0.0000593) and insigniﬁcant (p ¼ 0.62). Data are
summarized in Table 3.
Follow-Up
The mean clinical follow-up period was 72.0 ! 30.9
months (median 71.9; range, 13.9 to 143.8). One-year,
5-year, and 10-year survival estimation was 100%,
94.4% ! 2.5%, and 85.3% ! 5.3%, respectively. In total,
4 patients (3.9%) required aortic or aortic valve reopera-
tion during follow-up. One of those each underwent
AVR (because of endocarditis), arch replacement with
elephant trunk stage-1 procedure, open descending aortic
replacement, and abdominal aortic replacement. No pa-
tient required replacement of the primarily untouched
root or had dissection of the proximal aorta. Freedom
from aortic/aortic valve reoperation was 100%, 96.6% !
1.9%, and 93.9% ! 3.2% at 1, 5, and 10 years, respectively;
and freedom from aortic root events (aortic root
replacement, aneurysm, or dissection of the untouched
root) was 100% each at 1, 5, and 10 years.
Comment
Growth Behavior of Aortic Root and Other Portions
The aortic root, deﬁned anatomically by the scaffold of
the valve leaﬂets (aortic annulus) inferiorly and by the
sinotubular junction superiorly, grows on average 0.41
mm per year after root-sparing aortic replacement. Other
portions of the aorta show a considerably higher growth
rate. In a recent study from our group, we evaluated the
growth rates from our institutional database at the Aortic
Institute at Yale–New Haven and found a growth rate of
2.0 mm per year in the ascending and arch portion, 2.26
mm per year in the descending aorta, and 2.3 mm per
year in the thoracoabdominal sector (data are displayed
in Fig 1) [15]. The dilation over time in these portions also
increases with larger diameter. Given these preliminary
data, the results of the present study indicate that the
aortic root dilates at a rate almost ﬁvefold less than all
other parts of the aorta at the same size.





Age, years 61.8 ! 12.5
Male 61 (59.8)
Characteristics
Weight, kg 85.1 ! 19.1
Height, cm 172.0 ! 10.5
Body mass index, kg/m2 28.6 ! 5.2





Bicuspid morphology 47 (46)
Comorbidities
Coronary artery disease 23 (22.5)
Arterial hypertension 86 (84.3)
Dyslipidemia 50 (49.0)
Diabetes mellitus 7 (6.9)
Chronic renal failure 3 (2.9)
History of stroke 4 (3.9)
History of smoking 26 (25.5)
Values are mean ! standard deviation or n (%).
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Although the macroscopic morphology of the aorta
suggests a continuous and homogeneous network of tis-
sue, the aorta is actually composed of distinct microscopic
structures. The regional heterogeneity begins during
embryogenesis [16, 17] and impacts the elasticity deter-
mining aortic media. The aortic media tunic, impaired by
the remodeling process in aneurysms, consists of elastin,
collagen, and vascular smooth muscle cells. These smooth
muscle cells, derived from different embryologic origins,
are suspected to affect the activity of matrix metal-
loproteinase [5], for example, differently in different
aortic regions [18]. The vascular smooth muscle cells
forming the tunics of the aortic root, originate from the
secondary heart ﬁeld—a derivate of the lateral plate
mesoderm. The cells of the ascending aorta and aortic
arch originate from the neural crest, and the descending
portion is built by paraxial mesoderm (so-called “somatic
mesoderm”) [16–18]. These embryologic differences likely
effect not only the development of aneurysms, but
also the long-term adult behavior. Furthermore, the
“seams” between the different originating regions are
hypothesized to be the vulnerable locations of the aorta
and predisposing areas of aortic dissection [16].
Clinical Implications
Guidelines, published as a consensus paper of multiple
associations, recommend replacing the aortic root in
nonsyndromic patients at 55 mm or at a dilation of 5 mm
or more per year [6–8]. Given the growth rate in the
present study, the aortic root, found with an initial
diameter of 37.4 mm (in patients aged 62 years on
average), would not meet the 50 mm threshold for more
than an immense 29 years. Only patients with a diameter
of 45 mm and above are found to be at any substantial
risk of a contemporary growth up to critical root dilation
(at approximately 10 years after initial surgery). Our
institutional policy regarding root replacement—in con-
sent with many high-volume and specialized academic
centers—anticipates intervention at lower thresholds
than guidelines state, and recommends surgery at 45 mm.
These ﬁndings attest strongly to the safety of root-
sparing aortic replacement in case of nonaneurysmal
roots. The root-sparing technique, used in all patients of
Table 2. Estimated Average Annual Growth Rates of Aortic Root by Initial Size
Initial Aortic Size











25 mm 0.27 0.27 0.26 0.28 0.26
30 mm 0.32 0.33 0.31 0.33 0.31
35 mm 0.37 0.38 0.35 0.39 0.36
40 mm 0.43 0.43 0.42 0.44 0.41
45 mm 0.48 0.49 0.48 0.50 0.47
50 mm 0.51 0.54 0.53 0.55 0.52
Mean, 37.3 mm 0.41 0.42 0.40 0.42 0.40
AVR ¼ aortic valve replacement; BV ¼ bicuspid valve; TV ¼ tricuspid valve.
Fig 1. Annual growth rates according to different portions of the
aorta: aortic root (bright blue line); ascending aorta and arch (dark
blue line); descending aorta (green line); and thoracoabdominal aorta
(brown line). (Data on the ascending aorta and arch, descending
aorta, and thoracoabdominal aorta were evaluated and taken from a
recent publication of our group [15]).
Fig 2. Aortic diameter according to initial aortic root size and growth
rate: 25 mm (triangles); 30 mm (open circles); 35 mm (solid di-
amonds); 40 mm (solid circles); and 45 mm (open diamonds). Study
mean was 37 mm (open squares). Horizontal dashed line represents
the 50 mm diameter threshold.
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the present cohort, replaces the ascending aorta superior
to the level of the aortic valve suspension (sinotubular
junction), and consequently, the coronary arteries (alter-
native terms: supracoronary or supracommissural), and
leaves the native root tissue in situ. Sparing the root is the
technically more simple approach compared with root
replacement procedures (composite replacements, valve-
sparing, remodeling, and so forth) because of lack of
coronary artery reimplantation, and results in excellent
clinical outcomes [9, 19–22]. Leaving the root behind in
ascending aortic replacements, both De Paulis and col-
leagues [23] and Park and associates [24] noted that
neither a progressive dilation of nonreplaced sinuses nor
an incidence of root reoperations is evident in aneurysm
patients, in contrast to aortic dissection. Their ﬁndings
support the thrust of the current paper.
Dilation of the native root over time, however, is just
one component of the complex decision whether to
address the aortic root. Pathology and phenotype of the
aortic aneurysm, underlying aortic valve pathology and
its functional correlates, and the operative risk of primary
aortic root replacement or of a potential reoperation at the
aortic root need to be taken into account and individually
weighed. In a separate upcoming publication, we report
long-term outcomes of more than 600 aortic root re-
placements done contemporaneously with the patients
reported in this study; our results, like those at other
experienced centers, conﬁrm the low risk of aortic
replacement at high-volume institutions [10]. Therefore,
the root-sparing procedures in our current report were
accumulated because we believed they were appropriate
for the patients and their anatomy—not out of any
concern that full aortic root replacement was too
dangerous.
A concomitant replacement of the aortic valve showed
no signiﬁcant impact on the growth rate of the aortic root.
Any hypothesized effect of a proximal afﬁxation by the
prosthetic scaffold, either positively as root stabilization
or negatively as decreased stretching capability, could not
be conﬁrmed.
Impacting Factors
The morphology of the aortic valve, which shares the
neural crest as embryonic heritage with the ascending
aorta [25], appeared not to affect the growth rate in the
present study. Della Corte and colleagues [26] reported in
bicuspid (but nonoperative) patients a growth rate of 0.3
mm per year, comparable to the 0.42 mm per year in our
study. They also found a correlation between root
phenotype of the aorta and valve morphotype with right-
left fusion. In total, 41% in their cohort had an increase of
the root diameter over time.
The most important impact on root dilation is exerted
by the Marfan syndrome. Based on a mutation in the
FBN1 gene encoding ﬁbrillin-1 [27], Marfan patients had
progressive dilation of the root (approximately 60% to
84% of all patients [28]) with the risk of dissection,
rupture, and valve regurgitation. The growth rate in this
connective tissue disorder was estimated to be approxi-
mately 1.5 mm per year by Lazarevic and colleagues [29]
in 2006, and therefore was 3.5-fold higher than in the
present nonsyndomic cohort. Although Meijboom and
colleagues [30] calculated only a rate of 0.42 mm per year
for males and 0.38 mm per year for females, 1 in 7 men
and 1 in 9 women showed a fast growing root of more
than 1.5 mm per year, resulting in a signiﬁcant increase of
aortic dissection in those patients (both studies examined
nonsurgical patients). Therefore, an aortic replacement in
root-sparing technique is not recommended for patients
with syndromic diseases.
Study Limitations
The study is retrospectively based on a relatively small
number of patients with an imaging interval between ﬁrst
and most recent image of approximately 3.5 years, which
potentially raises concerns about selection bias and
generalizability. Advanced analysis focusing on the in-
ﬂuence of age, sex, valve pathology, and comorbidities
were denied statistically owing to small subgroup sizes.
Thin slices (5 to 10 mm), orthonormal projection, and
electrocardiography-gated imaging were preferred, but
not available in all cases (especially for patients operated
on in the earlier years of this study). We made every effort
to evaluate the size in a plane perpendicular to the blood
ﬂow (avoiding obliquity); we made full use of all images
available, including axial, coronal, and sagittal. Further-
more, follow-up scans were measured in the very same
projection and modality used for the baseline measure-
ments; therefore, technical issues should not signiﬁcantly
inﬂuence the change in size.
Table 3. Results of Regression Models
Eq. Variable Adj. R2 F
Coefﬁcient
T Statistic p ValueMean 95% CI
4.1 TIME 0.38 122.77 0.00065 0.00053–0.00077 11.08 <0.0001
4.2 TIME 0.38 61.10 0.00067 0.00046–0.00088 6.28 <0.0001
AVR !0.000023 . 0.18 0.857
4.3 TIME 0.38 61.27 0.00063 0.00048–0.00078 8.21 <0.0001
BICUSPID 0.000059 !0.00018–0.00030 0.49 0.622
Interaction terms between growth rate, time (TIME), and both aortic valve replacement (AVR) and bicuspid valve morphology (BICUSPID). The equation
numbers refer to the numbering in the Methods section.
Adj. ¼ adjusted; CI ¼ conﬁdence interval; Eq. ¼ equation.
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As noted, 9 patients were excluded because of incom-
plete follow-up, which was deﬁned as inadequate quality
of the images (for example, distorted projection, lack of
contrast [CT], solely axial images [CT], or no available
reconstruction [CT]), incomparable projection between SB
and SL, or, if raw images were not available, lack of pre-
cise aortic root measurement. Two patients were classi-
ﬁed as outliers by measurements greater than two
standard deviations from the mean, and excluded based
on the recommendation of our collaborative statistician.
Even if they would be included into the study, however,
the results are little affected.
Conclusions
The aortic root grows signiﬁcantly more slowly than the
remaining portions of the aorta. Neither a concomitant
AVR nor the valve morphology appears to impact its
growth rate. Seen in conjunction with clinical results, the
replacement of the aorta by a root-sparing technique is an
appropriate and safe approach, even in the long run, for
patients with a root diameter less than 45 mm. Decision
making with regard to aortic root procedures requires a
multidimensional view, however; knowing the efﬁcacy
of a root-sparing approach is one important step in this
process.
Dr Peterss is kindly supported by a research fellowship (PE 2206/
1-1) of the Deutsche Forschungsgemeinschaft (DFG), Bonn,
Germany.
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V-shape noncoronary sinus remodeling in ascending aortic
aneurysm and aortic root ectasia
John A. Elefteriades, MD,a Sven Peterss, MD,a Nariman Nezami, MD,b Gina Gluck, MD,b Wei Sun, PhD,c
Maryann Tranquilli, RN,a and Bulat A. Ziganshin, MDa,d
ABSTRACT
Objective: The study objective was to describe our initial experience performing
a V-shaped single sinus remodeling procedure in patients with ascending aortic
aneurysm and moderate aortic root ectasia.
Methods: Twelve consecutive patients underwent supracoronary ascending aortic
replacement with V-shaped noncoronary sinus remodeling (median age, 63 years
[range, 56-77]; 10 patients [83%] were male). All patients had an ascending aortic
aneurysm (median diameter 48 mm [range, 42-53]) and aortic root ectasia (me-
dian root diameter, 43 mm [range, 38-49.7 mm]). A deep V-shaped (triangular)
portion of the noncoronary sinus was excised, and thewall was directly reapproxi-
mated in 2 layers, 1 evertingmattress suture layer followed by a running over-and-
over layer.
Results: No technical complication due to root remodeling was observed. All
patients survived the initial hospitalization. Only 1 patient required reexploration
for bleeding, unrelated to the V-shaped repair. On postoperative computed
tomography, every patient showed reduction in maximal aortic root diameter
and cross-sectional area. Mean aortic root diameter was reduced from 4.30 cm
(range, 3.82-4.97) to 3.81 cm (range, 3.58-3.96) (P< .0006). Mean aortic root
cross-sectional area was reduced from 1452 mm2 (range, 1327-1615) to
1180 mm2 (range, 961-1328) (P < .0002). Mean wall tension decreased
postoperatively by 12%.
Conclusions: The V-shaped resection of the noncoronary sinus is a viable option
for patients with moderate aortic root enlargement. This technique reduces aortic
root diameter, cross-sectional area, and wall tension. We offer this technique as
another option in the surgeon’s armamentarium. (J Thorac Cardiovasc Surg
2017;154:72-6)
V-shaped noncoronary sinus resection procedure for
remodeling of aortic root.
Central Message
The V-shaped resection of the noncoronary si-
nus is a viable option for patients with moderate
aortic root enlargement.
Perspective
V-shaped resection of the noncoronary sinus is
a simple, quick, reliable supplement to
ascending aortic replacement for patients with
moderate aortic root enlargement. This tech-
nique reduces aortic root diameter, cross-
sectional area, and wall tension. This approach
is useful in elderly patients and those requiring
extensive surgery for primary pathologies
outside the aortic root.
See Editorial Commentary page 77.
The aortic valve cusps, the annulus, and the sinuses of
Valsalva work as 1 functional unit. Restoring or remodeling
such a unit adequately is beneficial for functional long-term
prognosis.1 Ascending aortic aneurysms often include the
sinotubular junction (STJ) and extend into the root portion
of the aorta, but most commonly affect the noncoronary or
right coronary sinus.2 Such pathologies (ascending aneu-
rysm with root ectasia) often result in aortic insufficiency.
Full aortic root replacement will eradicate all the pathology
of the valve, root, and ascending aorta. However, this may
represent excessive surgical intervention for an elderly or
infirm patient. Valve-sparing aortic root replacement is
another option (often accompanied by valve repair);
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however, the same proviso applies regarding the magnitude
of operation for the old or infirm. Urbanski and colleagues3
has described a more limited approach, with resection of 1
or more sinuses, which are replaced by a shield-shaped
patch.
We have accumulated initial experience with a simpler
and more expedient option, especially suited to elderly
patients, in whom extensive aortic root surgery for sinus
ectasia may not be warranted. These are patients generally
undergoing operation primarily for ascending aneurysm
(body of the ascending aorta), with only mild to moderate
enlargement of the aortic root, in the range of 4 to 5 cm.
For younger patients and for those with severe root
enlargement greater than 5 cm, we use full aortic root
replacement. We occasionally apply the V-shaped aortic
root remodeling in somewhat younger patients who require
extensive additional surgery (eg, additional full aortic arch
replacement).
This article describes our initial experience performing
a straightforward V-shaped singular sinus remodeling
procedure in patients with ascending aortic aneurysm
and moderate aortic root ectasia. The V-shaped
resection is performed in the noncoronary sinus, the
most commonly affected among the 3 sinuses. We largely
confine application of this technique to cases in which the
aortic valve is simultaneously replaced, usually by a bio-
logical prosthesis in this age group. We hesitate to
perform this procedure without concomitant aortic valve
replacement, because sinus anatomy is changed and
aortic insufficiency may be induced, although we did
perform this occasionally with preservation of the native
valve. Induction of aortic insufficiency is not an issue
with concomitant aortic valve replacement. Of course,
concomitant aortic valve replacement is a common
requirement in the elderly age group because of degener-
ation or calcification of the valve leaflets.
MATERIALS AND METHODS
Surgical Technique
The patient is prepped and draped in a standard fashion, and a median
sternotomy is performed. Cannulation sites are chosen according to the
surgeon’s preference. After initiating cardiac arrest, the aorta is circularly
opened just above the STJ, and, if applicable, the aortic valve is replaced.
For remodeling the root, a deep V-shaped or triangular portion of the
noncoronary sinus is excised and the wall is directly reapproximated in 2
layers, 1 everting mattress suture layer (4-0 pledgeted Ethibond; Ethicon,
Somerville, NJ) and then a running over-and-over layer (4-0 Prolene).
The edges of the remnant portions of the noncoronary sinus come together
easily, without tension, even after a wide resection.
The proximal anastomosis of the ascending aortic replacement is
performed to the smaller cuff (equal to the new STJ) of the aortic root by
running suture. We often add a dab of BioGlue (CryoLife, Kennesaw,
Ga) at the site where the V-shaped resection comes together with the
proximal anastomosis of the main ascending aortic graft, for added
security. We routinely reinforce the posterior wall of nearly all aortic
anastomoses with multiple interrupted sutures (4-0 Ethibond; Ethicon)
for added security. After performing the distal aortic anastomosis, the
patient is weaned from cardiopulmonary bypass, and the procedure is
completed in the usual fashion (See Figure 1 and Video 1).
RESULTS
Patient Population and Operative Data
Between March 2013 and May 2016, 12 consecutive
patients underwent supracoronary ascending aortic
replacement with V-shaped noncoronary sinus remodeling.
Their median age was 63 years (range, 56-77), body mass
FIGURE 1. Artist’s rendition of V-shaped noncoronary sinus resection
procedure for remodeling of aortic root. A, Line of resection indicated.
B, Reapproximation after resection. C, Details of first everting layer of
pledgeted sutures and second running layer. D, End-to-end attachment of
ascending graft to remodeled aortic root.
Abbreviation and Acronym
STJ ¼ sinotubular junction
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index was 28.2 (21.9-39.1), and 10 (83%) were male. All
patients had ascending aortic aneurysms (median diameter
of 48 mm [range, 42-53] and aortic root ectasia [sizes given
later]). The aortic valve was severely diseased in 9 patients
(75%; 2 via stenosis, 7 via insufficiency) and showed mild
regurgitation in 3 patients (25%). Bicuspid morphology
was found in 3 patients (25%). Comorbidities included
coronary artery disease in 2 patients (17%), chronic
obstructive pulmonary disease in 4 patients (33%), and
arterial hypertension and dyslipidemia in 8 patients each
(67%). Left ventricular ejection fraction was 64% (range,
40-70), and creatinine level was 0.85 (range, 0.7-1.0).
All patients underwent supracoronary ascending aortic
replacement, 4 patients (33%) underwent hemiarch
replacement, and 2 patients (17%) underwent total arch
replacement. The aortic valve was replaced in 10 patients
(83%) and spared in 2 patients (17%, both with only
preoperative mild valve insufficiency and central jet).
Concomitant coronary artery bypass grafting was required
in 1 patient (8.3%).
Cardiopulmonary bypass and crossclamp times were
153.5 minutes (range, 131-202) and 107.5 minutes
(69-136), respectively. Hypothermic circulatory arrest was
required in 6 patients (50%; 28 minutes; 19.5!C).
Operative Outcome
No technical complication due to root remodeling was
observed, and the aortic valve achieved full competency
when preserved (n ¼ 2). One patient (8.3%) experienced
bleeding requiring reexploration (distal aortic site), and 5
patients (42%) developed postoperative atrial fibrillation.
Otherwise, no other postoperative morbidities were found.
Median length of stay in the intensive care unit and in
hospital were 4 days (range, 2-5) and 6 days (range, 5-8),
respectively. Step-down beds were difficult to obtain during
this period of time, and patients often stayed in the intensive
care unit for lack of beds for the majority of their hospital
stay.
Remodeling Outcome
Preoperative and postoperative aortic root diameters and
cross-sectional areas were compared by an independent
radiologist unfamiliar with the patients. These are listed
in Table 1. Corresponding contrast computed tomography
scans of good quality were available for 10 of the 12
patients. Every patient showed reduction in maximal aortic
root diameter and cross-sectional area. Mean aortic root
diameter was reduced from 4.30 cm (range, 3.82-4.97) to
3.81 cm (range, 3.58-3.96) (P< .0006). Mean aortic root
cross-sectional area was reduced from 1452 mm2 (range,
1327-1615) to 1180 mm2 (range, 961-1328) (P< .0002).
The simplified formula for Laplace’s law T¼ P3 D shows
that mean wall tension (Table 2) decreased by 12%.
We used the percent change in diameter to represent the
change in wall tension, because tension is proportional to
diameter.
DISCUSSION
The presented surgical technique represents a technically
simple and effective option to address moderate sinus
dilatation by remodeling the noncoronary sinus. This
technique accomplishes significant reduction in transverse
diameter and cross-sectional area of the aortic root, with
attendant reduction in tension in the aortic wall.
In this initial experience, the V-shaped remodeling was
accomplished safely. Only 1 patient required reexploration
for bleeding, unrelated to the V-shaped repair.
We believe that this V-shaped technique is appropriate for
elderly patients with moderate dilatation of the aortic root
segment who require aortic valve replacement for stenosis
TABLE 1. Dimensional parameters, comparing preoperative and












1 4.71 1597 3.96 1094
2 4.37 1521 3.96 1328
3 4.35 1521 3.90 1260
4 4.16 1529 3.96 1381
5 3.82 1229 3.75 961
6 4.97 1505 3.47 1017
7 4.57 1615 3.93 1271
8 4.30 1452 3.94 1228
9 4.02 1327 NA NA
10 4.16 1405 3.58 1182
11 NA NA NA NA
12 3.92 1272 3.61 1081
Mean 4.30* 1452y 3.81* 1180y
NA, Not available (because of noncontrast scan). *P<.0006. yP<.0002.
VIDEO 1. A video illustration of the V-shaped noncoronary sinus
resection procedure for aortic root remodeling. Video available at: http://
www.jtcvsonline.org/article/S0022-5223(16)31685-3/addons.
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or insufficiency. It also may be considered as a simple
option for addressing moderate dilatation of the aortic
root in patients requiring extensive surgery for other
segments of the aorta or for other concomitant cardiac
issues (eg, aortic arch replacement, coronary artery bypass,
mitral valve surgery). Of note, we do not recommend this
technique for patients with Marfan’s disease or other
connective tissue syndromes, because the tissue weakness
is too severe for any procedure short of full aortic root
replacement. However, such patients usually would present
with maximal dilatation at the root segment, so the root
would de facto be the primary focus of surgery.
Westaby and colleagues2 and Urbanski and colleagues3
have taken an approach of resecting the noncoronary sinus
(and other sinuses, when needed). However, both Westaby
and colleagues and Urbanski and colleagues use a
shield-shaped patch or graft extension to replace the
resected noncoronary sinus. Our technique differs in that
we approximate the tissues primarily after V-shaped
excision, thus accomplishing a reduction in the diameter
of the aortic root and reducing the wall stress in that area.
Our technique also is suitable for individuals with extensive
calcification of the aortic wall around the coronary ostia or
severe calcification of the proximal right or left coronary
arteries; root replacement may be especially hazardous in
such circumstances.
Westaby and colleagues2 and Urbanski and colleagues3
also noted that the noncoronary sinus is the most commonly
and earliest affected by dilatation. This observation is
consistent with the concept that branch vessels provide
support and reinforcement to the arterial wall. It has
been shown4,5 that excess collagen fibers reinforce
areas of arterial bifurcation, like biological ‘‘rebar.’’
Reinforcement from collagen surrounding the right and
left coronary arteries may underlie the relative protection
of the corresponding sinuses from dilatation.
V-shaped resection has the potential to distort the
noncoronary sinus, resulting in prolapse of the noncoronary
leaflet and aortic insufficiency. For this reason, we prefer to
apply the V-shaped resection when the aortic valve is being
replaced, in which case the biological or mechanical
prosthetic valve is immune to such distortion. When
preserving the valve, the technique of Ugur and colleagues6
is preferable; this technique replaces the dilated
noncoronary sinus with a tongue-like extension of the
main aortic graft, which is sutured into the bed of the
resected noncoronary sinus.
We do not recommend the V-shaped technique for aortas
greater than 5 cm in diameter, for which we recommend a
formal root replacement type procedure. It is possible that
our patients may have donewell without theV-shaped resec-
tion, but we are wary of leaving behind an aortic dimension
greater than 4 cm, for fear of the potential for late dilatory
consequences. In the current era of 3-dimensional aortic
printing from computed tomography scans, examining
printedmodelsmay facilitate and enhance resection strategy
for the noncoronary sinus.
Why not perform a full aortic root replacement in
everyone? We believe strongly in aortic root replacement
for severe root pathology. The senior author has personally
performed more than 500 aortic root replacements.7
However, we believe that full root replacement may be
more than needed when the major aortic pathology is
located elsewhere and, especially, when the patient is
elderly or the operation is extremely extensive because of
multiple pathologies outside of the aortic root zone. Also,
replacing the coronary buttons onto a graft adds a small
but important additional risk. In contrast to supracoronary
ascending replacement, which does not increase surgical
risk when performed concomitantly,8 aortic root
replacement carries additional technical complexity and,
thus, increases the operative risk slightly.7,9
In a recent study,10 we examined the annual growth rate
in an untouched aortic root after supracoronary aortic
replacement. We found slow growth of the nonresected
root (0.41 mm/y) and no instance of dissection in the
nonresected root segment. The projected time to reaching
a diameter for surgical resection (nominally 5.5 cm) was
more than 25 years. In the case of V-shaped noncoronary
resection, the root is made substantially smaller, so even
more indolent behavior of the root can be expected than
in our recent study of root sparing without V-shaped
resection. Furthermore, it is likely that extensive scarring
around the V-shaped resection site will discourage
dilatation or free rupture.
Study Limitations
We have reported a favorable but limited experience with
the technique of V-shaped resection of the noncoronary
sinus. More experience and a longer follow-up are required
TABLE 2. Reduction in wall tension
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to determine the appropriate potential role of this technique
in the surgeon’s armamentarium.
CONCLUSIONS
We report our initial experience with a simple, quick,
reliable V-shaped resection of the noncoronary sinus as a
supplement to ascending aortic replacement and aortic
valve replacement for patients with moderate aortic root
enlargement. This technique reduces aortic root diameter,
cross-sectional area, and wall tension. We have found this
approach useful in elderly patients and those requiring
extensive surgery for primary pathologies outside the aortic
root. We believe that this V-shaped resection technique
offers another alternative surgical technique for the
moderately dilated aortic root, between the full aortic root
replacement (which may be more than needed) and leaving
the root alone entirely (which may be less than needed). We
offer this technique as another option in the surgeon’s
armamentarium.
Conflict of Interest Statement
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Abstract
OBJECTIVES: The purpose of the study was to evaluate the operative outcome and the risk of retained proximal aortic tissue following the
root-sparing (RS) technique in acute aortic dissection type A (AADA).
METHODS: Between 2002 and 2014, 338 patients underwent repair of AADA; 74% of those were performed with the RS technique and
26% with root replacement (RR). The mean age was 62.4 ± 13.4 years (69% male) in the RS group and 56.1 ± 13.1 years (76% male) in the
RR group (P < 0.001). Aortic insufﬁciency 2+ or higher was present in 35% (RS) and 72% (RR, P < 0.001), and bicuspid morphology in 1%
(RS) and 16% (RR, P < 0.001).
RESULTS: Cardiopulmonary bypass time and cross-clamp time were signiﬁcantly lower in the RS group (199 ± 71 vs 274 ± 110 min; 108 ± 46 vs
169 ± 55 min; P < 0.001 each), while no difference was seen with regard to distal operative extent, the use of circulatory arrest and adjunct pro-
tection strategies. The postoperative incidence of bleeding (18 vs 34%; P = 0.003), low cardiac output (14 vs 29%; P = 0.002) and sepsis/systemic
inﬂammatory response syndrome (5 vs 12%; P = 0.037) were higher after RR, whereas mortality and survival did not differ between the groups.
The aortic root grows at 0.40 ± 0.13 mm/year after AADA and thus, the need for potential reoperation was estimated at greater than 40 years.
Freedom from root events after 5 and 10 years of follow-up was 97 and 92% in the RS group, and 100% each in RR group, respectively.
CONCLUSIONS: Both RS and RR procedures can be performed with an acceptable postoperative outcome and late survival in AADA. The RS
approach can safely be performed with excellent results in acute survival and stabilizes the native root for a long period of time.
Keywords: Aortic root • Natural history • Aortic dissection • Supracoronary ascending replacement • Root replacement • Aortic events
INTRODUCTION
The outcome of surgical management of acute aortic dissection
type A (AADA) has improved over recent decades due to advances
in surgical technique and equipment [1]. These improvements and
technical developments (e.g. haemostatic impregnated grafts and
frozen elephant trunk prostheses), however, also opened a debate
regarding the optimal balance between treating the urgent
necessities at that time and preventing potential late future com-
plications [2–4].
In this context, the optimal operative strategy regarding the
proximal aorta remains controversial [5]. Replacing the entire
aortic root (i.e. composite graft replacement and Bentall proced-
ure) appears as prognostically the safest pathway, but adds tech-
nical complexity and is potentially problematic due to the need
for mobilization and connection of the acutely dissected coronary
artery buttons [6]. A more conservative repair, by resecting the
ascending aorta in a supracoronary fashion [root-sparing (RS)
technique], represents the surgically easier approach with less
postoperative morbidity and mortality [7, 8], but leaves the native
root untouched and potentially problematic in the future.
In non-dissected aneurysmal patients (non-syndromic), the
annual growth rate of a spared root is !0.4–0.5 mm; conseque-
ntly, the need for a secondary root replacement (RR) after an
initial RS procedure is rather unlikely [9]. But, does this beneﬁt also
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apply equally in terms of AADA, or do we necessitate (with the
surgically easier approach) a higher incidence of reoperations
during follow-up [3]? And, does an untouched root increase the
secondary mortality due to the risk of rupture and/or repetitive
dissection in that area during long-term follow-up?
The aim of this study was to evaluate the effectiveness of RS
procedures and the integrity of the untouched root in AADA.
MATERIALS ANDMETHODS
Study design
All consecutive patients admitted with the diagnosis of acute type A
aortic dissection at Yale-New Haven Hospital (USA) and the
Medical University of Innsbruck (Austria) between 2002 and 2014
were retrospectively analysed by chart and image review. Patients
with syndromic connective tissue disorders (Marfan, Ehlers–Danlos
and Loeys–Dietz syndromes) and patients who were declined surgi-
cal intervention (e.g. due to age, comorbidities and malperfusion
syndrome) were excluded. The cohort was divided into two groups
according to the surgical approach of the proximal aorta. The RS
group included all patients who received an ascending aortic re-
placement above the commissures (supracoronary and supracom-
missural), whereas the RR group consisted of patients undergoing
replacement of the aortic root with reimplantation of the coronary
arteries (including conduit replacements, classical Bentall and David
procedures). Patients with aortic root repair by suture or glue (n = 17),
and replacement of solely the non-coronary sinus (n = 33), were
excluded due to unclear assignment to one of the groups.
Demographic characteristics, operative data and in-hospital post-
operative outcomes were comparatively analysed. Root events in-
cluding proximal aortic rupture, recurrent dissection of the residual
native root tissue, progressive root aneurysm (>55 mm inner diam-
eter) and secondary RR during follow-up were collected and
freedom from root events was calculated. Survival was determined
from the Social Security Death Index (US), Civil Registry Ofﬁce
(AUT) and chart review, and analysed using the Kaplan–Meier esti-
mation. The Human Investigation Committee of Yale University and
the University of Innsbruck approved this retrospective study.
Patient population and selection of surgical
technique
Between 2002 and 2014, 342 consecutive non-syndromic patients
admitted with an acute type A aortic dissection were intended for
surgical intervention. Among those, 4 patients (mean age 74.3 ± 8.1
years) died before implementing cardiopulmonary bypass (CPB),
due to rupture during transportation, anaesthesia induction or ster-
notomy. Thus, 338 patients were included in the study. Two
hundred and forty-nine (74%) received an ascending replacement
via the RS technique (RS group) and 89 (26%) underwent the RR
technique (RR group). The mean age was 62.4 ± 13.4 years in the RS
and 56.1 ± 13.1 years in the RR group (P < 0.001), and male gender
predominated in both groups [165 (66%) vs 68 (76%); P = 0.084].
The dissection extended to the descending aorta and below in
213 (86%) patients in the RS and 73 (83%) patients in the RR group
(P = 0.494). Patients’ demographic characteristics and comorbid-
ities are depicted in detail in Table 1.
Table 1: Demographic characteristics and comorbidities
Total population (n = 338) Root sparing (n = 249) Root replacement (n = 89) P-value
Age (years) 60.7 ± 13.5 62.4 ± 13.4 56.1 ± 13.1 <0.001
Male gender 233 (69%) 165 (66%) 68 (76%) 0.084
BMI (kg/m2) 27.5 ± 5.2 27.6 ± 5.4 27.1 ± 4.8 0.499
Extension
Limited to ascending portion 52 (15%) 36 (15%) 16 (17%) 0.494
Involving descending aorta 286 (85%) 213 (86%) 73 (83%) 0.494
Supra-aortic extension 212 (63%) 153 (62%) 59 (66%) 0.523
Aortic valve
Insufficiency II° plus 148/332 (45%) 87 (35%) 61 (72%) <0.001
Bicuspid morphology 17/337 (5%) 3 (1%) 14 (16%) <0.001
Clinical presentation
Tamponade 68 (20%) 50 (20%) 18 (20%) 1.000
Pericardial effusion 162 (48%) 126 (51%) 36 (40%) 0.109
Neurological abnormality 50/324 (15%) 39 (16%) 11 (13%) 0.492
Malperfusion 58/315 (18%) 41 (18%) 17 (21%) 0.513
Resuscitation 25 (7%) 14 (6%) 11 (12%) 0.056
Comorbidities
Bovine arch 54 (16%) 45 (18%) 9 (10%) 0.092
Coronary artery disease 54/315 (17%) 47 (20%) 7 (9%) 0.036
COPD 31/315 (10%) 26 (11%) 5 (6%) 0.281
Renal insufficiency 38/315 (12%) 27 (11%) 11 (14%) 0.549
Creatinine (mg/dl) 1.20 ± 0.78 1.19 ± 0.84 1.26 ± 0.57 0.399
Hypertension 255/315 (81%) 199 (84%) 56 (72%) 0.021
PAD 22/316 (7%) 18 (8%) 4 (5%) 0.611
Hx of neurological abnormality 10/315 (3%) 8 (3%) 2 (3%) 1.000
Data are shown as mean ± standard deviation, number (percentage) or as [reported]. CAD was evaluated either by patients’ medical history or, recently, by CT
angiogram. Statistical significant level was defined at P≤ 0.05 (bold values).
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The selection of surgical technique and extent is recommended
by the institutional policies as follows: a RR is indicated by a severely
dissected left- or right-coronary sinus or at a root diameter of 45
mm and above. In younger patients, patients with bicuspid valve
morphology or a diseased valve (each characteristic signiﬁcantly dif-
ferent between the groups; Table 1), and in patients with Marfan’s
syndrome (excluded from this study), the root was replaced at lower
diameters according to the individual decision by the surgeon.
Aortic root diameter and growth rate
Aortic root diameter in the RS group was evaluated via CT scan
images, echocardiographic images or corresponding reports (in a
descending order for preference) and measuring the inner diam-
eter. For each patient, the postoperative baseline diameter (ﬁrst
available diameter after surgery) and the last follow-up diameter
were taken. The growth rate of the aortic root was estimated
according to Rizzo et al. [10] and, in a second step, compared with
the rate of growth in aneurysmal (non-dissection) patients from a
very recent study performed by the Aortic Institute [9].
The key variables in this analysis are FIRST SIZE (SF), classiﬁed as
the ﬁrst evaluated root diameter after surgery, LAST SIZE (SL), clas-
siﬁed as the last available root diameter during follow-up, and
TIME (T), classiﬁed as the Δ time between both images. The equa-
tion deﬁning aortic growth is written as
SL ¼ SFexpða # Tþb # StudyGroup # TÞ; ð1Þ
where exp denotes the exponential function, StudyGroup repre-
sents a binary variable (equal 1 for dissection patients and equal 0
for aneurysmal patients), α and β are coefﬁcients to be estimated,
and other terms are as deﬁned above.
For estimation purposes, we took a natural logarithm of both




¼ a # Tþb # StudyGroup # T: ð2Þ
The SL/SF was calculated for all patients and values ±2 SD from the
mean deleted to eliminate outliers.
Statistical analysis
Data are presented either as frequency distribution and percen-
tages for categorical variables, or as mean ± standard deviation for
continuous variables. The Pearson’s χ2 test or Fischer’s exact test
was used for analysing categorical variables, and the Student’s
t-test or Mann–Whitney U-test was used for continuous variables.
Survival was estimated by using Kaplan–Meier analysis, and the
log-rank test was used to compare survival between the groups.
Statistical analysis was performed using IBM® SPSS® Statistics
version 23.0 (IBM®, Inc., Armonk, NY, USA) in collaboration with
the Departments of Economics and Preventive Medicine of Stony
Brook University (Stony Brook, NY, USA).
RESULTS
Operative data and intraoperative mortality
The aortic root was replaced using the valve-sparing technique
(David V procedure) in 12 (14%) and using a conduit graft in 77
(87%) patients. Five (7%) of the RRs were done with a concomitant
modiﬁed Cabrol procedure due to technical difﬁculties involved
in the coronary artery buttons [11]. In the RS group, 22 patients
(9%) underwent aortic valve replacement, via either the
intra-annular or supra-annular technique, and 37 (15%) received a
suture valve resuspension (if the valve showed a regurgitation of 2
+ or higher, but without structural deterioration), according to the
surgeon’s preferred technique. Two hundred and forty-two (97%)
underwent circulatory arrest in the RS group versus 86 (97%) in
the RR group (P = 0.727), without any difference between the
groups regarding cerebral and organ protection strategy. Total
CPB (prolonged by 75 min on average in the RR group) and cross-
clamp time (prolonged by 61 min on average in the RR group) dif-
fered signiﬁcantly between the groups (P < 0.001). Arterial cannu-
lation site was distributed equally among the groups. Further
operative details are given in Table 2.
Eleven (3%) patients died intraoperatively, 7 of those after RS
ascending replacement and 4 after RR (P = 0.489). Causes of
intraoperative death were rupture (RS: 1; RR: 0), bleeding (RS: 2;
RR: 2) and low cardiac output (RS: 4; RR: 2).
Early postoperative outcome and late survival
The postoperative morbidities differed signiﬁcantly with regard to
bleeding requiring re-exploration [42 (18%) in RS vs 29 (34%) in
RR; P = 0.003], low cardiac output [32 (14%) in RS vs 25 (29%) in
RR; P = 0.002] and sepsis/systemic inﬂammatory response syn-
drome [11 (5%) in RS vs 10 (12%) in RR; P = 0.037]. Intensive care
unit and in-hospital stay were prolonged in the RR group by 2.1
(P = 0.198) and 5.1 days (P = 0.048), respectively. Operative mortal-
ity showed no statistically signiﬁcant better outcome in the RS
group [38 (15%) vs 18 (20%) in the RR group (P = 0.319)]. Further
postoperative information and mortality data are listed in detail in
Table 3. Kaplan–Meier estimation (Fig. 1) showed no difference
between late survivals of both the groups (P = 0.840).
Aortic root diameter and growth rate
In total, 105 (42%) patients undergoing ascending replacement via
the RS technique had adequate postoperative measurements of
the root portion. Among those, 8% showed a baseline diameter
between 45 and 50 mm and 4% larger than 50 mm. The mean
baseline diameter of the root (SF) was 37.8 ± 4.9 mm (range 24.2–
51.4) and the mean last diameter (SL) was 39.4 ± 5.0 mm (range
26.8–56.3), taken an average of 39.1 ± 31.4 months after the base-
line imaging. Hence, following the methodology described above,
the root did grow over time (coefﬁcient for TIME: 0.0009374;
P < 0.001) and the rate equated to 0.40 ± 0.13 mm/year (mean).
Furthermore, associated growth rates were higher with larger
baseline diameter, as depicted in Fig. 2. Compared with the exclu-
sively aneurysmal (non-dissected) diseased aortas [9], the non-
resected root of dissection patients showed no signiﬁcant different
rate of dilatation (coefﬁcient for TIME and StudyGroup: −0.0002249;
P = 0.064).
Aortic root events
Seven (3%) patients suffered from root events after initial sparing
of the native root during aortic replacement (none in the RR
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group). One patient (age 50, male) underwent conduit graft re-
placement due to bleeding complications on the ﬁrst post-
operative day and expired intraoperatively. Another patient (age
70, female) developed progressive aortic valve regurgitation after
8.7 years and required RR. She died on the ﬁrst postoperative day
due to low cardiac output syndrome. Graft infection (age 53, male,
32 months postoperation) and sinus of Valsalva rupture (age 59,
female, 11 months postoperation) were seen in one case each, and
both required reoperation. Three patients developed aortic root
aneurysm (age 61, 69, 70; 2 males; 10, 51 and 84 months post-
operation); 2 of them underwent surgical correction, and 1
declined surgery. No new dissection within the root was noted.
Strictly speaking, the bleeding, regurgitation and infection events
are counted here but not directly related to sparing the aortic root.
In total, freedom from root events after 1, 5 and 10 years of
follow-up was 99, 97 and 92% in the RS group and 100% each in
the RR group, respectively (Fig. 3).
Of note, 2 patients with aortic valve resuspension and RS
ascending replacement needed aortic valve replacement during
follow-up.
DISCUSSION
The basic surgical management of AADA seeks primarily to avoid
life-threatening aortic rupture and organ malperfusion, to close
the entry tear and to re-establish blood ﬂow to the aortic true
lumen. More extensive treatment aims to eliminate secondary
aortic dilatation, re-dissection and reoperation [2, 12]. However, a
prophylactic/preventive approach entails certain additional op-
erative risks. Regarding the proximal aorta, the question arises
whether to replace the aortic root proactively (with need for cor-
onary artery reimplantation) or to spare the root for the sake of
surgical simplicity.
Clinical results
In the present study, a higher incidence of bleeding complica-
tions requiring re-exploration, low cardiac output and sepsis or
severe inﬂammatory response syndrome were found in patients
who underwent RR. Stroke and postoperative paresis were not
inﬂuenced by the proximal aortic approach, as expected. Time
on CPB and ischaemia time of the heart were extended in the RR
group (75 and 61 min longer) reﬂecting the higher technical com-
plexity. The technical complexity of RR originates from the surgical
technique itself [6], and thus, procedure-typical and self-evident
complications like bleeding and insufﬁcient myocardial preserva-
tion or perfusion (resulting in low cardiac output) are the conse-
quences, as found in the present and other studies [3, 5, 7].
Despite these noted morbidities, no difference in operative
mortality was found between RR and the more conservative RS
technique in the present study, despite a trend favouring the
technically simpler approach (operative mortality 15 vs 20%),
Table 2: Operative data
Total population (n = 338) Root sparing (n = 249) Root replacement (n = 89) P-value
Prior cardiac procedure 21 (6%) 15 (6%) 6 (7%) 0.801
Cardiopulmonary bypass
Time (min) 219 ± 89 199 ± 71 274 ± 110 <0.001
Cross-clamp time (min) 124 ± 56 108 ± 46 169 ± 55 <0.001
Circulatory arrest 328 (97%) 242 (97%) 86 (97%) 0.727
Time (min) 39 ± 18 40 ± 19 39 ± 16 0.777
Lowest temperature (°C) 20 ± 3 19 ± 3 20 ± 3 0.085
DHCA alone 130/335 (39%) 104 (42%) 26 (29%) 0.032
w/RCP 52/335 (16%) 39 (16%) 13 (15%) 0.865
w/SACP 144/335 (43%) 97 (39%) 47 (53%) 0.034
Arterial cannulation site
Aorta 19 (6%) 16 (6%) 3 (3%) 0.422
Axillary 120 (36%) 90 (36%) 30 (34%) 0.796
Femoral 199 (59%) 143 (57%) 56 (63%) 0.451
Proximal aorta
Aortic valve replacement 99 (29%) 22 (9%) 77 (87%) –
Valve resuspension 37 (11%) 37 (15%) – –
David procedure 12 (4%) – 12 (14%) –
Conduit root replacement 77 (23%) – 77 (87%) –
w/modified Cabrol 5 (2%) – 5 (7%) –
Ascending replacement 338 (100%) 249 (100%) 89 (100%) –
Aortic arch
Hemiarcha procedure 277 (82%) 202 (81%) 75 (84%) 0.630
Arch replacement 51 (15%) 40 (16%) 11 (12%) 0.491
Descending aorta 17 (5%) 14 (6%) 3 (3%) 0.575
Elephant trunk stage-I 6 (2%) 4 (2%) 2 (2%) 0.656
TEVAR 11 (3%) 10 (4%) 1 (1%) 0.300
Concomitant CABG 39 (12%) 26 (10%) 13 (15%) 0.334
Data are shown as mean ± standard deviation, number (percentage) or as [reported]. Statistical significant level was defined at P≤ 0.05 (bold values).
aDefined as the use of circulatory arrest including arch inspection, selective arch tear suturing, open distal anastomosis and partial/subtotal arch replacement.
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consistent with other studies (18 vs 21% [5]; 8 vs 23% [13]). This
trend might be a reﬂection of higher disease complexity in the RR
cohort, requiring more extensive proximal aortic replacement
(treatment bias). Di Eusanio and the IRAD group identiﬁed, in
their study of 1995 patients, younger age, Marfan’s disease, bicus-
pid morphology, diseased aortic valve, coronary artery dissection,
larger root diameter and dissection into the root portion as selec-
tion parameters towards RR, which might explain the frequently
found distribution of !1 : 2 to 1 : 3 (RR : RS) [3, 5, 12, 13]. Among
those biasing factors, age (along with less incidence of coronary
artery disease and arterial hypertension in the younger patients)
differs by 5–8 years on average between both the groups [2, 3, 5, 12]
and was shown to be independently associated with higher mortality
in older patients [3].
Safety of a spared root
The aortic root grows slowly after ascending replacement by the
RS technique, on average 0.40 ± 0.13 mm/year [ranging from 0.26
to 0.63 mm/year according to the initial size (25–60 mm)]. Hence,
a guideline conformed RR (55 mm) would mathematically be
indicated after 43 years (range 27–58 years). These ﬁndings are
consistent with the data published by Rylski et al. [14]. They also
found a very slow growth rate of 0.6 ± 1.1 mm/year at an initial
size of 41.8 ± 6.3 mm (37.8 ± 4.9 mm in the present study), but noted
a signiﬁcantly higher growth rate of 1.3 ± 1.3 mm/year in patients
requiring later reoperations compared with 0.2 ± 0.7 mm/year in
those without. In comparison with the other portions of the aorta,
the root of dissection patients appears to grow signiﬁcantly slower
[15] and equally to the aortic root of solely aneurysmal patients
(Fig. 2).
Replacing the aortic root prophylactically aims for the preven-
tion of secondary dilatation (incidence !7–13%), recurrent dissec-
tion (3–7%), suture line and pseudoaneurysm (3–5%) and aortic
valve insufﬁciency (3%), and for avoidance of reoperation (7–16%)
after sparing the root [3, 13, 14]. The freedom from root reinter-
vention is published at 99% after 3, 88–95% after 5 and 77–83%
after 10 years [3, 5, 13, 16]. In the present study, the freedom from
root events after the RS procedure was even higher at 97% after 5
years and 92% after 10 years. The count of secondary root dilata-
tion and rupture was low, and no recurrent dissection was noted
in the spared root portion. Even though the RS group was signiﬁ-
cantly older, survival showed no inferiority of an unreplaced root,
which might have been expected due to later aortic events in the
untouched proximal portion.
In our tabulation of later aortic events, uncommon as they were,
we used a very liberal deﬁnition of late events. Bleeding, progres-
sive aortic valve insufﬁciency and graft infection may not be appro-
priately reﬂective of negative impact from sparing the root.
Table 3: Postoperative outcome and follow-up
Total population Root sparing Root replacement P-value
Morbiditiesa
Bleeding req. re-exploration 71 (22%) 42 (18%) 29 (34%) 0.003
Ventilation >48 h 133 (41%) 93 (39%) 40 (47%) 0.248
Tracheostomy 17 (5%) 11 (5%) 6 (7%) 0.403
Low cardiac output 57 (18%) 32 (14%) 25 (29%) 0.002
Mechanical assist 10 (3%) 7 (3%) 3 (4%) 0.728
Stroke/cerebral bleeding 48 (15%) 34 (14%) 14 (17%) 0.723
Paresis 23 (7%) 16 (7%) 7 (8%) 0.630
Malperfusion 32 (10%) 22 (9%) 10 (12%) 0.530
Haemofiltration 68 (21%) 45 (19%) 23 (27%) 0.125
Multi-organ failure 27 (8%) 16 (7%) 11 (13%) 0.108
Sepsis/SIRS 21 (7%) 11 (5%) 10 (12%) 0.037
Staysb
ICU stay (days) 8.3 ± 10.8 7.8 ± 10.3 9.9 ± 12.1 0.198
In-hospital stay (days) 16.0 ± 15.0 14.7 ± 12.4 19.8 ± 20.3 0.048
Operative mortalityc 56 (17%) 38 (15%) 18 (20%) 0.319
Exitus in tabula 11 (3%) 7 (3%) 4 (5%) 0.489
In-hospital mortality 53 (16%) 37 (15%) 16 (18%) 0.499
30-day mortality 53 (16%) 37 (15%) 16 (18%) 0.499
Survival
Follow-up (months) 66.0 ± 45.5 66.4 ± 43.7 64.8 ± 50.9 0.782
1 year 80 ± 2% 81 ± 3% 76 ± 5% –
5 years 76 ± 2% 77 ± 3% 73 ± 5% –
Clinical follow-upb,d (months) 55.8 ± 44.2 55.3 ± 42.6 57.2 ± 48.9 0.601
Freedom from root events (months) 55.7 ± 44.3 55.2 ± 42.6 57.2 ± 48.9 0.601
1 year 99 ± 1% 99 ± 1% 100%
5 years 98 ± 1% 97 ± 1% 100% –
10 years 94 ± 3% 92 ± 4% 100% –
Data are shown as mean ± standard deviation, number (percentage) or as [reported]. Statistical significant level was defined at P≤ 0.05 (bold values).
ICU: intensive care unit; req.: requiring; SIRS: systemic inflammatory response syndrome.
aExcluding patients who died intraoperatively.
bIncluding only discharged patients.
cThirty-day mortality plus all in-hospital deaths after 30-days.
dTen of 285 discharged patients (4%) were lost for clinical follow-up.
S. Peterss et al. / European Journal of Cardio-Thoracic Surgery236
	 76	
	
Balanced treatment of the proximal aorta
According to our results, both RS technique and RR can be per-
formed with acceptable morbidity and mortality in AADA. Even
though replacing the root prophylactically appears as a ‘bulletproof’
solution in the long run [2, 3, 12], a supracoronary ascending re-
placement with a spared root can be performed with excellent
early and late results without major detriments in secondary com-
plications and late survival. This is a very appropriate operation,
except in Marfan syndrome or Marfanoid pattern root dilatation
Figure 2: Growth rate of the aortic root. The ﬁgure presents the growth rates according to the initial diameter of non-syndromic patients with aortic dissection.
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[5, 6]. In young patients, those with connective tissue disease (i.e.
Marfan’s syndrome), diseased valve with bicuspid morphology and
root dilatation >40 mm, a RR is strongly recommended.
Limitations
The major limitation of our study is its retrospective nature, asso-
ciated with inherent limitations of such analysis. The use of glue
was limited in the included patients to adhering the layers, to
sealing the anastomosis or stabilizing the anastomotic site; how-
ever, data regarding the application technique and the type of
glue were incomplete and thus, excluded from further analysis.
The treatment bias (more frequent aortic RRs in young, bicuspid
and diseased valve patients [5]) also applies for the present study
as in others and its impact on the growth rate (e.g. by treating
bicuspid morphologies predominately with an RR) remains un-
known; however, randomized studies comparing the treatment of
the proximal aorta are lacking. The absence of this type of study
and the fairly consistent trends seen in our patients’ characteristics
suggest that our ﬁndings are meaningful.
CONCLUSIONS
With regard to the proximal aorta, the technically simpler RS tech-
nique is associated with less postoperative morbidity, but similar
operative mortality. During the follow-up course, the growth rate
of the untouched root is slow, secondary root events are low and
survival shows no inferiority. Thus, sparing the root, if not indi-
cated separately [5], can be safely performed with a good integrity
for a long period of time.
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APPENDIX. CONFERENCE DISCUSSION
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Dr E. Beckmann (Hannover, Germany): My ﬁrst question is about the two
groups and the indication for surgery in the root replacement group. What was
the indication for the root procedure in this group and were the native roots of
the root sparing group completely native or were they dissected and glued?
Dr Peterss: The indication for root replacement at Yale, and also in Innsbruck,
was 45 mm and above. This was certainly an indication to replace the root. In
some cases, like in patients with bicuspid valve, and in younger patients (e.g.
younger than 50 years), and in patients with affected coronary arteries, we tend
to lower diameters, down to sometimes 40 mm. Can you please repeat your
second part of the question?
Dr Beckmann: Was there any glue repair or was it completely native aortic
tissue?
Dr Peterss: Patients with noted root repair by glue or similar techniques were
excluded from this study. However, we don’t have complete data about the
concomitant application, but our institutional policy at Yale is to use Bio Glue
between layers.
Dr Beckman: I think it is important to make a difference between native
roots that are completely untouched and those that have been repaired due to
dissection or dilation. So I am not sure whether it is fair to compare those two
groups because basically there was an indication for root repair in the Bentall/
David group but not in the other group. Can you comment on this?
Dr Peterss: You are absolutely right. The problem with the comparability
arises from the retrospective character of this study. But as the previous speaker
mentioned, a propensity score matching analysis will end up with a lower
number of patients and in our case it was about 20 pairs. These propensity
matched patients did not reﬂect the results of the total population, because
these showed a much lower mortality and a much better outcome. That is the
reason, why we just compared overall groups. A selection bias, or better stated,
treatment bias affected most published studies. A prospective study which ran-
domizes patients to root replacement and no root replacement is, to the best
to my knowledge, not available in the literature so far. Such study might have
the potential to answer the question whether to replace the root or not. Or, if
you include large group populations into a study, a propensity matched score
analysis will show statistically strong results. But ﬁnally, the more clinical rele-
vant data you implement in the propensity score matching analysis, the lower is
your number of pairs and the weaker is your statistical analysis in the end and
thus the results.
Dr F. Emrich (Leipzig, Germany): The increased hospital stay, do you think
that’s really only related to the longer cross-clamp and bypass times, or were
the patients sicker?
Dr Peterss: I think in the end it’s multifactorial. We have a higher incidence of
preoperative resuscitation in the patients with a root replacement; we have a
need for longer CPB time and a more prolonged need for catecholamine
support. We also have a slightly increased incidence of stroke and a proportion-
al increase of haemoﬁltration in this group. This reﬂects the multifactorial
causes for hospital stay. But, as you’ve said, extended coronary bypass time
caused by the root replacement itself is an important factor.
Dr Emrich: Another question. You excluded the syndromes. What about
BAVs, did you look into those, whether they behaved differently?
Dr Peterss: We had about 5% of BAVs included in the study. These numbers
are too low to do a separate analysis by tricuspid versus bicuspid morphologies.
We know from the aneurysm patients—in total 102 analysed patients and who
hopefully will be published soon—that there is no difference in the growth rate
between tricuspid versus bicuspid valve morphologies in untouched roots after
root-sparing procedures. Does this also apply for dissection? Honestly, I don’t
know, but it is highly expectable.
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Abstract
OBJECTIVES: The objective of this study is to retrospectively analyse surgical outcomes in patients aged 75–79, and 80 and above.
METHODS: Between 2000 and 2015, 108 patients aged 75–79 (G75, mean age 76.9 ± 1.5years) and 72 patients aged 80 and above (G80,
mean age 82.2 ± 2.1years) underwent elective aneurysm repair. Operative outcome and survival was compared with 727 contemporary
younger counterparts aged <75 years (GCtrl, mean age 56.6 ± 11.7years).
RESULTS: Postoperatively, patients with advanced age showed a higher incidence of prolonged ventilation (G80 21.4%, G75 8.4%, GCtrl
2.9%; P < 0.001), low cardiac output syndrome (G80 11.4%, G75 1.9%, GCtrl 2.2%; P = 0.001), multi organ failure (G80 2.9%, G75 0%, GCtrl
0.1%; P = 0.022), haemofiltration (G80 8.6%, G75 0.9%, GCtrl 0.6%; P < 0.001), and infection (G80 10.0%, G75 6.5%, GCtrl 3.5%; P = 0.017).
Operative mortality was significantly increased in the elderly (G80 11.1%, G75 3.7%, GCtrl 1.4%; P < 0.001). Mid-term survival differed
significantly between the surgical groups. Multivariate regression analysis precluded age as an independent predictor of operative
mortality.
CONCLUSIONS: Elderly patients showed a higher operative risk compared to their younger counterparts. However, age per se is no suit-
able indicator of surgical risk and well-selected patients with large threatening aneurysms may benefit from intervention.
Keywords: Aortic aneurysm • Aortic surgery • Advanced age • Seniors • Octogenarians • Septuagenarians
INTRODUCTION
Technical advances in recent decades have made aortic surgery
safer and made surgical treatment of the aorta more accessible
to patients, even with an increased risk profile and advanced age
[1]. Nevertheless, aortic surgery—requiring prolonged cardiopul-
monary bypass times and the possible need for hypothermia and
circulatory arrest—still carries a substantial risk for older patients
who have suffered biological deterioration of the cardiovascular,
neurocognitive and renal systems via aging [2, 3]. Among elderly
patients, mortality for thoracic aortic surgery ranges between 6
and 21% [2–7], depending on the definition of the term ‘elderly’
and the extent of surgery. Age has been shown to be an
independent predictor of mortality both in cardiac surgery in
general and in aortic surgery in particular [1, 3, 8]. But, as we ex-
plore aortic surgery in advanced age, are we pushing the limits
too far or futilely?
The demographic structure of the Western countries has and
will further change. According to the US Census Bureau, the pro-
portion of octogenarians among the total population in the USA
will increase from 3.7% (11.7million) in 2012 to 3.9% (13.2 mil-
lion) for the 2020s and 7.7% (30.9 million) for the 2050s [9].
However, complex aortic surgery in the elderly and specifically
whether there should be a cut-off age for aortic surgery remains
debatable.
The aim of the present study was to evaluate the operative re-
sults of elective thoracic aortic aneurysm surgery in the elderly
in the 21st century. We classified patients into two age frames
(75–79 years, and >_80 years), and compared to their younger
counterparts.
†Presented at the AATS Aortic Symposium 2016, New York, NY, USA, 12–13
May 2016.
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This study was designed as retrospective analysis of our institu-
tional aortic database and was approved by the Human
Investigation Committee of Yale University. All consecutive pa-
tients undergoing surgical repair between 2000 and 2015 were
screened according to the inclusion and exclusion criteria.
The inclusion criteria included elective or urgent open aortic
surgery due to aneurysm disease of the root, ascending or the
arch portions of the aorta at any age. Exclusion criteria included:
aortic dissection, free aortic rupture, intramural haematoma,
penetrating aortic ulcer and thoracic aneurysm limited to the
descending and the thoraco-abdominal segment of the aorta.
The total population was divided into three groups:
• Patients who underwent aortic surgery for thoracic aneurysm
at age of lower than 75 ("control group", GCtrl),
• Patients who underwent aortic surgery at advanced age, div-
ided into
• Age 75–79 years (G75), and
• Age 80 years and older (G80).
We compared these groups according to demographic charac-
teristics and co-morbidities, surgical data, and operative results
and early outcome. Also, the predictors of mortality were eval-
uated statistically and mid-term survival was compared within
the groups (GCtrl, G75 and G80). Survival after discharge was deter-
mined by a multimodal follow-up assessment, as described re-
cently by our group [10]. Either the date of death or the last
confirmed clinical contact with the patient was counted as latest
follow-up date.
Statistical analyses
Data are presented either as frequency distributions and percent-
ages for categorical variables, or as mean ± standard deviation for
continuous variables. The statistical difference between the three
surgical groups (GCtrl, G75 and G80) was tested using the Fisher’s
exact test for categorical variables and the ANOVA test for con-
tinuous variables. Predictors of operative mortality were investi-
gated by both univariate analysis using Fisher’s exact test or
Student’s t-test, and binary logistic regression including variables
with a P-value <_ 0.10 from the univariate analysis. Operative mor-
tality was defined as in-hospital mortality plus patients who
expired after discharge within the first 30 days post-surgery. The
Kaplan–Meier survival estimation was used to analyse the
postoperative survival and the Mantel-Cox log rank tests to com-
pare the estimated survival of different populations. Statistical
analysis was performed using SPSSVR Statistics version 23.0 (IBMVR
Inc., Armonk, NY) in cooperation with the Departments of
Economics and Preventive Medicine of Stony Brook University
(Stony Brook, NY).
RESULTS
Population and demographic characteristics
In total, 907 patients who underwent surgery between 2000 and
2015 due to aortic root, ascending aorta or aortic arch aneurysm
are included in our institutional database (detailed age distribution
is presented in Fig. 1). Among those, 727 were younger than 75
years (GCtrl; mean age 56.6 ± 11.7 years), 108 were aged between
75 and 79 years (G75; 76.9 ± 1.5 years), and 72 were at age 80 and
older (G80; 82.2 ± 2.1). Gender and biometric data differed signifi-
cantly between the groups, with an increase of female patients at
higher ages and a decrease in body mass (each P < 0.001). The
prevalence of congenitally bicuspid aortic valves decreases signifi-
cantly with increasing age (P < 0.001). No Marfan’s syndrome pa-
tient was found in the elderly groups (P = 0.140).
With regards to the co-morbidities, the incidence of atrial fib-
rillation (P < 0.001), coronary artery disease (P < 0.001), chronic
renal failure (P < 0.001), dyslipidaemia (P = 0.004), arterial hyper-
tension (P = 0.002), and pulmonary hypertension (P < 0.001) were
just significantly increased at advanced age. Detailed data and
inter-group comparison are presented at Table 1.
Operative data
Patients younger than 75 years more frequently received a root
replacement compared to older patients (P < 0.001), while the
root was spared in the majority of the advanced age groups.
Distally, an extension into the arch—performing an open distal
anastomosis/hemiarch replacement (P < 0.001) or a total arch re-
placement (P = 0.011) (both under straight deep hypothermic cir-
culatory arrest)—was more often necessary in the elderly. Also,
the need for concomitant coronary artery bypass grafting
increased at higher ages (P < 0.001).
The cardiopulmonary bypass time was extended by 6.4mi-
nutes on average in G75 and 11.8min on average in G80
(P = 0.004), while the mean x-clamp time was comparable among
all groups (P = 0.844). Hypothermic circulatory arrest time was
also statistically prolonged (P = 0.005), but without clinical rele-
vance. Femoral cannulation was the prevailing method within all
groups; however, the frequency of direct aortic (P = 0.004) or axil-
lary cannulation (P < 0.001) was higher with increasing age (as we
avoid femoral cannulation when the thoraco-abdominal aorta is
‘dirty’ with arteriosclerosis). More details are shown in Table 2.
Figure 1: Caseload according to age between 2000 and 2015 at the Aortic
Institute at Yale–New Haven.
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Postoperative outcome and early mortality
The postoperative results and their analysis are presented in de-
tail in Table 3.
The elderly patients showed multiple statistically significant
deficiencies in postoperative outcome—a higher incidence of
ventilation over 48 h (P < 0.001), low cardiac output syndrome
(P = 0.001), myocardial infarction (P = 0.045), ventricular tachycar-
dia (P = 0.013), sepsis (P = 0.049), multi organ failure (P = 0.022),
haemodialysis (P < 0.001) and infection requiring antibiotic ther-
apy (P = 0.017). Proportional differences (compared to the
younger control group) were much higher pronounced in octo-
genarians rather than in patients aged between 75 and 79.
Postoperative ICU stay was prolonged on average by 1.5 days in
G75 and by 1.7 in G80 (P < 0.001). Respectively, hospital stay was
also extended by 1.3 and 2.6 days (P < 0.001) on average.
Operative mortality was significantly increased at higher ages
(P < 0.001).
Risk factor analysis
An univariate analysis isolated age (P = 0.001), bicuspid morph-
ology (P = 0.022), bovine arch (P = 0.049), left ventricular ejection
fraction (P = 0.039), coronary artery disease (P < 0.001), peripheral
artery occlusive disease (P = 0.018), cardiopulmonary bypass time
(P < 0.001), circulatory arrest time (P = 0.002), and concomitant
coronary artery bypass grafting (P = 0.014) as significant pre-
dictors of operative mortality. Among these variables, none was
found to be an independent risk factor in regression analysis.
Survival of the surgical groups
Mean follow-up was 74.9 ± 44.5 months for GCtrl, 49.0 ± 41.2
months for G75 and 44.3 ± 41.2 months for G80, respectively. The
survival differed significantly between the groups (Fig. 2) and
decreased with increasing age (P < 0.001). 1-, 3- and 5-year sur-
vival is presented in Table 3.
DISCUSSION
The biology of patients in their last decades changes by the ef-
fects of aging. Alterations in the pulmonary system affecting all
components of breathing (respiratory mechanic properties, gas
exchange and the pulmonary vasculature) [11], changes in the
cardiovascular system (e.g. left ventricular hypertrophy, impaired
left ventricular contractility and relaxation) [12], deterioration of
renal function (e.g. glomerulosclerosis, tubular atrophy and fibro-
sis) [13], hormonal imbalance between catabolic and anabolic
Table 1: Demographic characteristics
Control group aged <75 years Group 75 Group 80 P-value
n = 727 108 72
Age [years] 56.6 ± 11.7 76.9 ± 1.5 82.2 ± 2.1 <0.001
Male gender 541 (74.4%) 65 (60.2%) 34 (47.2%) <0.001
Biometry
Weight [kg] 88.2 ± 19.6 76.2 ± 15.0 72.5 ± 12.9 <0.001
Height [cm] 174.8 ± 11.6 169.5 ± 11.0 167.9 ± 10.6 <0.001
BMI [kg/m2] 28.9 ± 6.2 26.7 ± 4.5 25.7 ± 3.6 <0.001
BSA [m2] 2.03 ± .26 1.89 ± .22 1.82 ± .20 <0.001
Maximal aortic diameter 52.3 ± 9.1 53.2 ± 10.0 58.3 ± 10.8 0.007
Aortic valve disease 439 (60.5%) 68 (64.5%) 40 (56.9%) 0.597
Stenosis 147 (20.2%) 24 (22.4%) 11 (15.3%) 0.502
Insufficiency 292 (40.3%) 44 (41.1%) 29 (40.3%) 0.992
Valve morphology
Tricuspid 401 (55.2%) 84 (79.2%) 59 (92.2%) <0.001
Bicuspid 321 (44.2%) 22 (20.8%) 5 (7.8%) <0.001
Unicuspid 5 (.7%) 0 (-) 0 (-) 1.000
Congenital disorders
Marfan 18 (2.5%) 0 (-) 0 (-) 0.140
Bovine arch 12 (2.0%) 1 (1.1%) 3 (4.2%) 0.384
Co-morbidities
Atrial fibrillation 87 (12.0%) 21 (19.4%) 26 (36.6%) <0.001
Hx of smoking 283 (39.0%) 39 (36.1%) 20 (28.2%) 0.183
Coronary artery disease 85 (11.7%) 23 (21.3%) 32 (45.1%) <0.001
LVEF [%] 57.3 ± 10.2 57.8 ± 7.5 55.8 ± 9.7 0.706
COPD 60 (8.3%) 14 (13.0%) 10 (14.1%) 0.094
Chronic renal failure 36 (5.0%) 7 (6.5%) 13 (18.1%) <0.001
Diabetes 73 (10.1%) 12 (11.1%) 3 (4.2%) 0.250
Dyslipidaemia 317 (43.7%) 63 (58.3%) 40 (56.3%) 0.004
Arterial hypertension 526 (72.6%) 88 (81.5%) 63 (88.7%) 0.002
Pulm. hypertension 13 (1.8%) 4 (3.7%) 8 (11.3%) <0.001
Hx of stroke 29 (4.0%) 8 (7.4%) 0 (-) 0.040
Prev. cardiac surgery 66 (9.1%) 12 (11.1%) 8 (11.1%) 0.656
Data are shown as mean ± standard deviation, number (percentage) or as [reported]. The percentage values refer to the total number (n) of available informa-
tion.
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Table 2: Operative data
Control group aged <75 years Group 75 Group 80 P-value
n = 727 108 72
CPB [min.] 149.1 ± 30.9 155.5 ± 30.5 160.9 ± 42.2 0.004
X-clamp [min.] 101.5 ± 28.8 100.2 ± 32.2 99.9 ± 32.0 0.844
HCA 373 (51.4%) 76 (70.4%) 59 (81.9%) <0.001
HCA time [min.] 27.7 ± 6.7 29.7 ± 7.7 30.4 ± 7.8 0.005
HCA core temp. [!C] 18.8 ± .9 18.9 ± 1.2 18.7 ± 0.8 0.599
Procedure
Bentall 307 (42.2%) 29 (26.97%) 13 (18.1%) <0.001
Root sparing 420 (57.88%) 79 (73.1%) 59 (81.9%) <0.001
w/AVR 262 (36.0%) 51 (47.2%) 28 (38.9%) 0.084
Hemiarcha 320 (44.1%) 60 (55.6%) 49 (68.1%) <0.001
Arch Repl. 53 (7.3%) 16 (14.8%) 10 (13.9%) 0.011
ET stage-I 32 (4.4%) 8 (7.4%) 5 (6.9%) 0.239
Cannulation
Aorta 39 (8.7%) 14 (17.7%) 14 (19.4%) 0.004
Femoral 396 (88.0%) 56 (70.9%) 48 (66.7%) <0.001
Axillary 15 (3.3%) 9 (11.4%) 10 (13.9%) <0.001
Prosthesis
Mechanicalb 400 (72.1%) 13 (16.3%) 4 (9.8%) <0.001
Biologicalb 154 (27.7%) 67 (83.8%) 37 (90.2%) <0.001
Size [mm] 23.4 ± 2.3 22.3 ± 2.2 21.9 ± 2.1 <0.001
Add procedure 147 (20.2%) 32 (29.6%) 31 (43.1%) <0.001
CABG 95 (13.1%) 22 (20.4%) 25 (34.7%) <0.001
Mitral valve 3 (.4%) 0 (-) 2 (2.8%) 0.088
Tricuspid valve 1 (.1%) 0 (-) 1 (1.4%) 0.167
Data are shown as mean ± standard deviation, number (percentage) or as [reported]. The percentage values refer to the total number (n) of available informa-
tion.
AVR: aortic valve replacement; CABG: coronary artery bypass grafting; CPB: cardiopulmonary bypass; ET: elephant trunk procedure; HCA: hypothermic circu-
latory arrest; repl.: replacement; temp.: temperature.
a Hemiarch includes open distal anastomosis as well as hemiarch replacement, both with the need of HCA.
b Data refer to the number of implanted prosthesis.
Table 3: Postoperative outcome and survival
Control group aged <75 years Group 75 Group 80 P-value
n = 727 108 72
Morbidities
Bleeding 28 (3.9%) 6 (5.6%) 7 (10.0%) 0.059
Ventilation >48 h 21 (2.9%) 9 (8.4%) 15 (21.4%) <0.001
Tracheostomy 3 (.4%) 1 (.9%) 1 (1.4%) 0.254
Low cardiac output 16 (2.2%) 2 (1.9%) 8 (11.4%) 0.001
Myocardial infarction 4 (.6%) 2 (1.9%) 2 (2.9%) 0.045
Ventr. tachycardia 8 (1.1%) 3 (2.8%) 4 (5.7%) 0.013
AV block III! 16 (2.2%) 5 (4.7%) 4 (5.7%) 0.062
Pacemaker 26 (3.6%) 8 (7.5%) 5 (7.1%) 0.067
Multi organ failure 1 (.1%) 0 (-) 2 (2.9%) 0.022
Sepsis 2 (.3%) 0 (-) 2 (2.9%) 0.049
Stroke 8 (1.1%) 2 (1.9%) 2 (2.9%) 0.163
Renal failure 11 (1.5%) 2 (1.9%) 9 (12.9%) <0.001
Haemodialysis 4 (.6%) 1 (0.9%) 6 (8.6%) <0.001
Infection 25 (3.5%) 7 (6.5%) 7 (10.0%) 0.017
Stay [days]
Intensive care unit 3.0 ± 2.9 4.5 ± 5.8 4.7 ± 5.3 <0.001
In-hospital 6.4 ± 4.3 7.7 ± 6.3 9.0 ± 8.1 <0.001
Operative mortality 10 (1.4%) 4 (3.7%) 8 (11.1%) <0.001
Intraop. mortality 1 (.1%) 1 (.9%) 0 (-) 0.358
In-hospital mortality 8 (1.1%) 2 (1.9%) 8 (11.1%) <0.001
30-day mortality 10 (1.4%) 4 (3.7%) 8 (11.1%) <0.001
Survival
1-year 96 ± 1% 92 ± 3% 79 ± 5%
3-year 93 ± 1% 78 ± 5% 67 ± 6%
5-year 90 ± 1% 71 ± 5% 58 ± 7%
Data are shown as mean ± standard deviation, number (percentage) or as [reported]. The percentage values refer to the number of patients, who survived the
first postoperative 24 h.
h: hours; ventr.: ventricular.
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hormones towards the catabolic side, and neurocognitive dys-
function and neurovascular changes are commonly observed
with increasing age [14, 15].
Thus, not unexpectedly, the biometric data and incidence of
preoperative co-morbidities differ between the age-related
groups. The elderly groups showed preserved left ventricular
function and no significant difference in the frequency of chronic
obstructive pulmonary disease, diabetes, history of stroke, and
previous cardiac surgery compared to their younger counter-
parts, which might haul out these variables as subjective denial
criteria for older patients in our institute.
The aging changes in biology are also reflected in the postop-
erative morbidities. Patients at higher ages suffered from multiple
complications affecting the pulmonary, cardiovascular, renal, im-
munologic and multiple organ systems. However, the propor-
tional differences were markedly less pronounced in patients
aged 75–79 years rather than 80 and above. These data conform
to studies in the literature [6, 7, 8, 16]. Bleeding complications
ranged between 3–15% in these studies and were found in 5.6–
10.0% in the present study, likely reflecting increased tissue fragil-
ity at higher ages. Interestingly, stroke rate in the present study,
usually reported with significantly higher incidence in elderly (be-
tween 2–9% [3, 4, 6–8]), was low in the group aged >_ 80 years
(2.9%) and did not differ to their younger counterparts (1.1%),
despite the fact that 81.9% of the elderly underwent deep hypo-
thermic circulatory arrest of 30.4min on average. However, a
positive selection of healthier elderly patients in that age group
might have influenced these results.
Operative mortality, as the classical surgical surrogate of suc-
cessful treatment, increased significantly at higher ages. While pa-
tients aged between 75 and 79 again showed much lesser
increase of operative mortality, ages of 80 and above suffered
from surgery-associated deaths of up to 11.1%. Generally, mortal-
ity (in-hospital, 30-day or operative) ranges in the literature be-
tween 6 and 16% for general cardiac and aortic surgery and age
was frequently described as independent predictor. Safi and col-
leagues identified an age of 72 as cut-off for increased mortality,
while the present study showed good results in that specific age
group. The present study did not identify age as independent
predictor of postoperative mortality—representing outcome at
higher ages as multifactorial process-, and thus, according to our
data, we would specify the border of increased risk at a higher
age, around 80 years.
However, even if the operative risk for morbidity and mortality
increases at the age of 80, surgical intervention in threatening an-
eurysms with larger diameter may potentially eradicate the
higher risk from aortic rupture and dissection and thus, restore
patient outlook to baseline. This hypothesis is supported by the
literature reporting similar or better survival of surgically inter-
vened patients compared to medically treated patients, and free-
dom from aortic events due to intervention [17, 18].
However, for the elderly, restoring survival is not sufficient
without maintenance of quality of life [16, 19]. Also, as frailty
measures have emerged, surgeons have quantified that chrono-
logical and biological age as not identical [20, 21]. Such factors
enter into surgical decision for thoracic aortic disease as well as
general conditions for surgery.
LIMITATIONS
This is a retrospective study with the inherent limitations for such
analysis. Patients undergoing aortic surgery at higher age usually
underlie a positive selection bias, as described above. Beside the
denial by the patients themselves, the rejection by the surgeon
due to more complex co-morbidities was one of the common
causes of the decision toward medical treatment and thus, might
influence the survival of the particular subgroup.
CONCLUSIONS
Patients undergoing aortic surgery at advanced age are subject to
higher operative risk, particularly at the age of 80 and above.
However, in the present study, age per se is no suitable indicator
of operative outcome and thus, a strict age cut-off cannot be
deduced thereof. Surgery in well-selected octogenarians with ‘ur-
gent’ and threatening aortic sizes potentially restores survival and
patients may benefit from intervention, even above age 80.
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Abstract
OBJECTIVES: Surgical therapy for acute aortic dissection type A (AADA) in octogenarians carries high morbidity and mortality. The role of
isolated medical treatment in this setting is controversial. The aim of this study is to determine whether risk of surgery for AADA outweighs
risk of death from medical treatment only.
METHODS: From 2002 to 2015, 90 consecutive octogenarians (mean age, 83.5 ± 3 years) were treated for AADA at three institutions: 67
patients underwent surgery, 23 patients received medical treatment. Analysis of early and late outcome was performed.
RESULTS: Patients in the medical treatment group were significantly older than in the surgical group (84.9± 3.7 vs 83± 2.5 years, P= 0.008) and
in a more critical state. In patients undergoing surgical repair, perioperative mortality was 14.9% (n= 10). Rate of prolonged ventilation (63.2% vs
5.9%; P< 0.001) and renal failure (35.1% vs 5.9%, P= 0.029) was significantly higher in the surgical group. Thirty-day survival was impaired in the
medical treatment group (34.8% vs 61.2% in the surgical group; P= 0.032). Coronary artery disease (OR 3.95, 95% CI 1.16–13.49; P= 0.029) and
complicated dissections (OR 5.28, 95% CI 1.48–18.88; P= 0.010)—composite variable of preoperative resuscitation, neurological injury and
malperfusion—emerged as independent risk factors for 30-day mortality in the surgical group. There was no difference in long-term survival.
CONCLUSIONS: Emergency surgery for AADA in octogenarians is associated with relatively high intraoperative mortality and may reason-
ably be avoided in patient with complicated presentation. Despite better immediate survival after surgery, long-term survival does not dif-
fer between medical and surgical patients, reflecting the extremely advanced point in life cycle octogenarians.
Keywords: Octogenarians • Type A aortic dissection • Surgery • Medical treatment • Survival benefit
INTRODUCTION
The steadily increasing life expectancy carries substantial increase of
octogenarians in Western society (up to 3-fold by 2050, according to
recent data of the US Census Bureau) [1]. Concurrently, the number of
elderly patients undergoing elective as well as emergent cardiac surgi-
cal procedures is increasing. A population-based study by Howard
et al. [2] predicts a proportion of patients over the age of 75 suffering
from aortic dissection of over 50% in future years. Surgical therapy for
acute aortic dissection type A (AADA) in octogenarians carries high
morbidity and mortality. In order to improve the outcome of such
advanced age patients, a modified surgical treatment towards a less
invasive replacement has been suggested [3]. Although the literature
still considers surgery as the primary option, little is known about out-
come of AADA in octogenarians when treated medically [4–7].
Therefore, this study compares early and late outcome in octogenar-
ians suffering from AAD undergoing either medical or surgical treat-
ment. The aim of this study is to determine whether risk of surgery
for AADA outweighs risk of death from medical treatment only.
MATERIALS AND METHODS
Study design
Three institutional surgical databases (Department for Cardiac
Surgery, Medical University Innsbruck/Austria, Department for
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Cardiac Surgery, Leipzig Heart Centre/Germany, Yale Aortic
Institute, New Haven/USA) were retrospectively reviewed to
identify patients aged older than 80 years suffering from AADA
between 2002 and 2015. Patients’ charts and imaging data were
analysed and survival follow-up was evaluated. The institutional
review boards approved this study.
Between January 2002 and August 2015, a total of 90 octogen-
arians (mean age, 83.5 ± 3 years) were admitted due to AADA to
three international institutions. Patients were divided into two
groups based on the treatment (n = 67 surgical treatment, n = 23
medical therapy). Patient characteristics are listed in Table 1.
Treatment groups
All patients were evaluated by a cardiac surgeon. The decision
for surgical or medical treatment was primarily driven by the pa-
tient’s condition at presentation and comorbidities. After evalu-
ation of imaging studies and risk assessment, risks and benefits of
surgical treatment were explained to the patients and their fami-
lies and a final decision was made.
If surgical treatment was therapy of choice, the patient was
taken to the operation room and induction of anaesthesia was
performed immediately. Once cardiopulmonary bypass (CPB)
was established, systemic cooling was initiated. Depending on
the extent of the dissection and the surgeon’s consideration, the
distal anastomosis was either performed via aortic cross clamping
or in an open fashion during circulatory arrest. After careful
evaluation of the primary entry site, replacement of the aortic
root, the ascending aorta, the aortic arch or a combination of
these structures was performed. Aortic arch replacement was
performed in case of a pre-existing arch aneurysm or an entry
tear or ulceration located in the convexity of the aortic arch,
which could not be excluded by partial arch replacement.
In case of medical therapy, all patients were initially shifted to
the intensive care unit. Once haemodynamic monitoring was
instituted, hypertensive patients received intravenous vasodila-
tors and beta-blockers in order to decrease blood pressure and
vascular stress. In addition, pain medication or light sedation was
administered to achieve maximal comfort for the patient.
Outcome and follow-up analysis
Patients who died intraoperatively or within 24h postoperatively
were defined as early deaths (n= 16, 17.8%). Renal failure was
defined as the need for either haemofiltration or dialysis due to
acute renal insufficiency. Tracheotomy was performed in patients
with prolonged ventilator support and failure to be weaned from
the respirator. Postoperative neurological injury was defined as per-
manent new neurological deficit and/or brain injury detected on
computed tomography (CT) or magnetic resonance imaging (MRI)
scan. Follow-up information was obtained using Social Security
Death Index, telephone interviews or outpatient clinic visits.
Statistical analysis
Statistical analysis was performed using SPSS 23.0 (SPSS Inc.,
Chicago, IL, USA). Categorical variables are expressed as fre-
quency distributions and percentages; continuous variables are
expressed as mean ± standard deviation. Chi-square test was
used for categorical variables. If observed frequencies were <5,
Fisher’s exact test was used for categorical variables. Student’s
t-test was applied for continuous variables.
Table 1: Baseline characteristics and preoperative data
Variable Surgical treatment Medical treatment P-value
(n = 67) (n =23)
Age (years) 83.0 ± 2.5 84.9 ± 3.7 0.008
Male sex 33 (43.3) 10 (43.5) 0.809
Body mass index (m2) 26.1 ± 5.3 28.1 ± 7.8 0.211
Comorbidities
Hypertension 54 (80.6) 19 (82.6) 1.000
Diabetes 15 (22.4) 2 (9.1) 0.221*
Coronary artery disease 18 (26.9) 9 (40.9) 0.285
Hyperlipidaemia 24 (37.3) 12 (54.5) 0.213
Peripheral vascular disease 9 (13.4) 0 (0) 0.105*
Preoperative creatinine level 1.4 ± 1 1.4 ± 1 0.959
Previous cerebrovascular accident 6 (8.9) 4 (18.2) 0.260*
COPD 8 (11.9) 7 (31.8) 0.047*
De Bakey classification
Type I 36 (53.7) 15 (65.2) 0.465
Type II 31 (46.3) 8 (34.8) 0.465
Malperfusion syndrome 11 (16.7) 7 (30.4) 0.226*
Neurological symptoms at presentation 6 (9.1) 6 (26.1) 0.069*
Preoperative intubation 5 (7.6) 5 (21.7) 0.116*
Pericardial effusion 24 (35.8) 17 (73.9) 0.003
Tamponade 20 (29.9) 4 (17.4) 0.287
Preoperative CPR 5 (7.6) 1 (4.3) 1.000*
Redo surgery 8 (11.9) 4 (17.4) 0.494*
COPD: chronic obstructive pulmonary disease; CPR: cardiopulmonary resuscitation. Results are given in mumber (%) or mean ± standard deviation.
Significance level (for bold values) was P < 0.05.
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In order to adjust for selection bias a regression model was cre-
ated for 30-day mortality as well as overall mortality: all factors
showing significant difference between the two treatment groups
in univariable analysis or P < 0.10 were considered for multivari-
able analysis. Multivariable analysis did not remain statistically sig-
nificant after adjusting for the following factors: age, chronic
obstructive pulmonary disease (COPD), pericardial effusion and
preoperative neurology (Table 2).
Factors influencing 30-day mortality in the surgical group were
explored by separate univariable analysis in a first step. Factors
showing significant influence or clinical relevance were then taken
to multivariable analysis using logistic regression. For description
of long-term survival Kaplan–Meier curves were calculated; groups
were tested by log-rank and Gehan–Breslow–Wilcoxon test to de-
termine differences in early and long-term survival. Differences in
survival rates during the early period are reflected by Gehan–
Breslow–Wilcoxon test, whereas P-value of log-rank test is based
on differences in long-term survival.
For comparing survival after discharge with expected survival
of an age- and gender-adjusted normal population, each patient
was individually matched and followed according to life-table
survival data from the Centers of Disease Control and Prevention
for intercensal years 2000 [8]. A single-sample log-rank test was
employed for assessing the difference between operative and ex-
pected survivals. The life-table year was selected to correspond
to the mean and median year of surgery.
RESULTS
Patient characteristics
Female gender was predominant in both treatment groups. Patients
in the medical treatment group were significantly older than surgical
patients. In terms of risk factors and comorbidities groups only dif-
fered in rate of COPD. Patients in the medical treatment group were
in a more critical state at point of admission with significantly higher
rates of pericardial effusion and a strong trend towards more neuro-
logical symptoms. Details are given in Table 1.
Surgical therapy
Out of 67 patients in the surgical treatment group, three patients
(4.5%) died from aortic rupture during induction of general
anaesthesia and before initiation of CPB could be performed.
In most patients, arterial cannulation was performed through
the right axillary artery (n = 32, 50%) or the femoral artery (n = 22,
34.4%). The ascending aorta was used for cannulation only in
rare cases (n = 10, 15.6%). In most patients (n = 52, 81.3%), deep
(18–21 !C) or moderate (24–27 !C) hypothermic circulatory arrest
was performed in order to allow an open distal anastomosis.
Mean circulatory arrest time was 25.3 ± 18.5min. In 12 patients
(18.8%), a less invasive quick replacement was performed via aor-
tic cross clamping. Most of these patients (n = 8, 66.7%) presented
with De Bakey type II dissections. For all patients, mean aortic
cross clamp time was 90 ± 48.6min, mean CPB time was
177.6 ± 69.1min. An isolated ascending replacement was per-
formed in most patients (n = 52, 81.3%). Root replacement was
necessary in six patients (9.4%) and six more patients (9.4%)
needed supplemental aortic valve replacement. Aortic arch re-
placement was limited to eight patients (12.5%) and coronary ar-
tery bypass grafting to 10 (15.6%).
In-hospital outcome
Overall 16 patients (17.8%) died within 24 h after admission to
the hospital with no difference between the treatment groups
(surgical n = 10, 14.9% vs medical n = 6, 26.1%; P = 0.342). Table 3
gives details on causes of early deaths. In the remaining 74 sur-
vivors, prolonged ventilation (more than 48 h) was more fre-
quently necessary in patients undergoing surgical therapy (n = 36,
63.2% vs medical n = 1, 5.9%; P < 0.001); 11 patients (19.3%)
underwent tracheotomy after surgical treatment due to weaning
Table 2: Multivariate regression analysis for 30-day mortality and Cox regression model for overall survival
30-Day mortality Overall survival
OR 95% CI P-value HR 95% CI P-value
Surgical treatment 0.62 0.19–2.02 0.426 0.88 0.42–1.82 0.722
Age 1.18 0.99–1.40 0.60 1.09 0.99–1.20 0.068
Pericardial effusion 1.48 0.57–3.82 0.418 1.30 0.74–2.29 0.368
Preoperative
neurology
2.49 0.60–10.31 0.208 0.69 0.30–1.58 0.377
COPD 0.98 0.29–3.37 0.980 1.30 0.65–2.61 0.458
CI: confidence interval; COPD: chronic obstructive pulmonary disease; HR: hazard ratio; OR: odds ratio.







Aortic rupture 4 (40) 2 (33.3)
Heart failure 4 (40) 3 (50)
Diastolic failure due to tamponade 1 (10) 3 (50)
Coronary malperfusion 3 (30) 0
Hypovolaemic shock 1 (10) 0
Uncontrollable bleeding 2 (20) 0
Multiorgan failure 0 1 (16.7)
Results are given in number (%) or mean ± standard deviation.
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failures. Also, rate of renal failure requiring haemofiltration or
haemodialysis was significantly higher in the surgical group
[n = 20, 35.1% vs n = 1, 5.9%; P = 0.029 (according to Fisher’s exact
test)]. In 11 patients (19.3%) in the surgical group imaging (CT or
MRI scans) revealed strokes. Three of these patients had neuro-
logical abnormalities at admission before surgery. Mean ICU as
well as in-hospital stay was longer in the surgical group
(10.5 ± 1.3 vs 3.8 ± 0.8 days in the medical group; P = 0.015 for
ICU stay, 15.7 ± 14.2 vs 5.4 ± 4.3 days in the medical group;
P = 0.001 for in-hospital stay).
Further morbidities are listed in Table 4.
In-hospital mortality did not differ significantly between the
groups (32.8% for surgical vs 47.8% for medical treatment;
P = 0.218). However, 30-day mortality was significantly higher in
the medical treatment group (65.2% vs 38.8% in the surgical
group; P = 0.032).
Age-adjusted multivariable analysis identified coronary artery
disease (OR 3.95, 95% CI 1.16–13.49; P = 0.029) and complicated
AADA (OR 5.28, 95% CI 1.48–18.88; P = 0.010)—defined as a com-
posite variable including preoperative cardiopulmonary resusci-
tation, preoperative neurological injury or preoperative
malperfusion syndrome—as independent risk factors for 30-day
mortality in patients undergoing surgical treatment.
Late survival
Mean follow-up period was 19.6 ± 32.2 months. Overall survival
of octogenarians suffering from AADA, regardless of treatment,
was 42.7 ± 5.3%, 33.1 ± 5.4% and 26 ± 5.6% at 1, 3 and 5 years.
Figure 1 illustrates impaired overall survival in octogenarians suf-
fering from AADA when compared with an age- and gender-
matched control.
Surgical treatment leads to improved survival when compared
with medical treatment (Breslow P = 0.030), with 1- and 3-year
survival of 48.5 ± 6.2% and 37.5 ± 6.5% for the surgical group and
25.4 ± 9.2% and 19 ± 8.8% in the medical group. Beyond 5 years,
survival does not differ between the two treatment groups (log-
rank P = 0.077). Further details are shown in Fig. 2.
DISCUSSION
This study presents the experiences of three large and specialized
aortic centres in Europe and North America and thus reflects one
of the largest octogenarian cohorts suffering such disease. The
natural course and prognosis of AADA is known to be devastat-
ing; complications often occur before admission or in an early
phase, frequently associated with fatal outcome.
Octogenarians with AADA are frequently in a severe clinical
state when admitted to the hospital and carry a broad spectrum
of comorbidities due to their age. A multicentre study by
Piccardo et al. [6] reports a rate of complicated dissections
(defined as neurological deficits, mesenteric ischaemia or cardio-
pulmonary resuscitation) of 20.2%. The extent of early complica-
tions is also confirmed by Neri et al. [7], showing high rates of
organ malperfusion (up to 41%) or cardiac tamponade (in 62%)
of octogenarians. The impact of organ malperfusion or haemo-
dynamic instability is severe, even more so in this advanced age
population [9, 10].
In this study, beside presence of coronary artery disease, com-
plicated dissection emerged as independent risk factors for 30-
day mortality after operative repair in this study, emphasizing the
importance of the preoperative state of the patients. These fac-
tors reflect the surgeon’s dilemma of finding a reasonable






Ventilation > 48 h 36 (63.2) 1 (5.9) <0.001
Tracheotomy 11 (19.3) 0 (0) 0.059*
Low output syndrome 12 (20.7) 9 (40.9) 0.066
Multiorgan failure 11 (19) 0 (0) 0.060*
Sepsis 5 (8.8) 0 (0) 0.583*
Stroke 11 (20) 2 (10.5) 0.498*
Haemofiltration/haemodialysis 20 (35.1) 1 (5.9) 0.029*
Results are given in number (%). Significance level (for bold values) was
P < 0.05.
*P-value based on Fisher’s exact test. Figure 1: Actuarial survival of octogenarians suffering from acute aortic dissec-
tion type A compared with age- and gender-matched US population.
Figure 2: Overall survival of octogenarians suffering from acute aortic dissec-
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treatment for a fragile patient already suffering from complica-
tions of a lethal cardiovascular disease.
Although the role of surgical treatment of AADA in octogenar-
ians has been controversial, most centres still promote surgery as
the best treatment option for AADA in octogenarians based on
the dismal natural history of the disease. However, surgical ther-
apy for AADA is associated with high intra- or perioperative mor-
tality in octogenarians, with in-hospital mortality rates up to 83%
[7]. Almost 15% of patients expired during surgery in the present
series, whereas other groups report even higher rates up to 33%
[7]. High surgical mortality results most frequently from either
aortic rupture or uncontrollable bleeding. Although survival is
the primary aim of surgical treatment of AADA patients, surgeons
need to recognize that aggressive therapy still leads to lethal out-
come in many octogenarians. In patients at this age, the combin-
ation of preoperative conditions (comorbidities and
complications), age and frailty themselves inflict poor early
outcome.
Medical treatment as an alternative option for AADA is often
preferred in patients with advanced age or multiple comorbid-
ities but is associated with very poor outcome. In this study co-
hort, age was an important but not the only criteria for medical
treatment. Factors influencing surgeons to recommend or choose
medical treatment were either comorbidities or the patient’s sta-
tus at admission (neurological impairment, intubation or resusci-
tation before admission). In almost 30% it was the patient or the
patient’s family, who declined surgical repair. Survival rates of
only 70–72% within the first 24 h after the event reflect the grave
natural prognosis of the disease [11, 12]. Data from the
International Registry of Acute Aortic Dissection revealed a 30-
day mortality of 58% in patients treated medically, regardless of
age [12]. The role of medical treatment especially in elderly pa-
tients has been investigated in very small cohorts only. Trimarchi
et al. [5] reported an in-hospital mortality of 55% in 29 octogen-
arians receiving medical treatment. Slightly higher in-hospital
death rates have been found by Yanagisawa (57%) and Hata
(60.7%) as well as this study (65.7%) [13, 14].
However, in this study, we found 30-day survival was signifi-
cantly better in the surgical group, although postoperative com-
plications were high in surgical patients. In AADA and especially
in older patients with limited capacity, the first few days after sur-
gical repair seem to divide survivors from non-survivor. In-hos-
pital outcome was dismal in both treatment groups and early
postoperative mortality rates were tremendously high.
Nevertheless, once surgical patients could be stabilized in the
early postoperative phase, survival improved in contrast to pa-
tients receiving medical treatment. Thirty-day survival data reflect
this trend in both treatment groups. Unfortunately, survival in
surgical patients was accompanied with high rates of postopera-
tive complications. In addition to a trend towards higher rates of
strokes, more than 35% of patients in the surgical group suffered
from renal failure requiring haemofiltration or dialysis. Obviously,
these complications do significantly impact quality of life.
Although the usual measures of treatment outcome (postoper-
ative morbidity, mortality and survival) favour surgical therapy,
regenerative capacity also becomes a limiting and striking factor
in the elderly. A complete restoration of autonomous life postop-
eratively is highly doubtful, as shown previously [15]. Given these
circumstances and the finding of our study, conservative treat-
ment for AADA in the elderly may be appropriate in many cases,
especially with comorbidities or complicated initial presentation.
Limitations of the study
This study has a number of limitations. First, data acquisition and
analysis in the different databases was done retrospectively.
Second, despite the multicentricity of the study, the absolute
number of patients remains small. Especially the group of octo-
genarians receiving medical treatment is limited. Therefore, uni-
or multivariable calculations of risk factors for hospital mortality
could only be performed for the surgical group. Third, only octo-
genarians who were admitted or referred to the three study
centres alive were included. The hospital databases miss the sub-
stantial proportion of octogenarians suffering from AADA but
expiring at home or on the way to the hospital. Fourth, follow-up
period was limited due to the advanced age of the study popula-
tion. Survival was the only study end-point evaluated in the fol-
low-up period. Quality of life and functional outcome would be
interesting factors to be evaluated. Most importantly, the choice
of treatment—medical versus surgical—was not randomized. This
certainly accounts for a strong selection bias in the study, reflect-
ing the consulting surgeon’s assessment of the patient’s chances
of surviving surgery and deeming the more seriously ill popula-
tion into the medical treatment group.
CONCLUSIONS
We compared medical and surgical treatment of acute ascending
aortic dissection in octogenarians. Surgical treatment is associ-
ated with lower 30-day mortality rates and better early survival
when compared with medical treatment. Long-term survival be-
yond 5 years does not differ, reflecting the extremely advanced
age point in the life cycle. Individualized preoperative evaluation
and selection of these patients remain essential. Respecting and
accepting the disease—acute ascending aortic dissection—as a po-
tential mode of death should be considered, especially in compli-
cated dissections. Medical treatment represents a reasonable
option in octogenarians.
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